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White blood cells (WBCs) and their subtypes are important constituents of the 
human immune system as their concentration, quantified by a WBC count test, indicates 
the state of body’s immune response against infections. These cell count tests are 
important prognostic and diagnostic indicators for a number of human immunological 
diseases, most prominent of them being AIDS. Flow cytometry (FC) is the gold standard 
for counting WBCs. Although high throughput and accurate, FC based instruments are 
bulky, expensive and require skillful and trained personnel for their operation and 
maintenance. This necessitates the development of inexpensive, portable point-of-care 
(POC) systems for capturing and enumerating WBCs and their subtypes.  
 
We envision a portable, point-of-care WBC counting system which can capture 
thousands of WBCs and simultaneously image and count them. Towards this end, we 
have developed: 
- A microfluidic biochip for trapping and counting WBCs. The biochip has a novel 
3D cell trapping architecture and enables simultaneous capture and counting of 





- Microlens arrays with a large field of view (FOV) imaging capability that have an 
optical performance (numerical aperture, resolution) equivalent to a conventional 
microscope objective. 
   
 We envision that the cell trapping biochip and the microlens arrays proposed in 
this thesis can be integrated to perform simultaneous on-chip capture and 
imaging/counting of WBCs. The integrated microsystem can also be used as a generic 
platform for sorting and enumeration of different kinds of cells for disease diagnosis and 







1.1 Motivation  
Globalization and rapid industrial growth has led to significant improvement in 
the average standard of living of the people worldwide. This economic prosperity has 
spurred increased health awareness amongst the people from developed and developing 
countries. These people now subscribe to regular health checkup programs at their nearby 
hospitals and health clinics to keep a periodic record of their health and to prognose a 
disease or a disorder in its early state. However, lack of time due to busy work schedule 
and hectic urban life makes it difficult to make these regular hospital visits. Thus there is 
a huge demand to develop benchtop biomedical systems which are affordable and 
portable enough to be installed in one’s house and which have diagnostic and monitoring 
performance comparable to the state-of-the-art equipments in the hospitals and health 
clinics.  
 
On the other end of the health management spectrum are the underdeveloped 
regions of the world like the ones in sub-Saharan Africa and South Asia where there is an 
immense shortage of basic infrastructure like water, electricity and sanitation and hence 
are termed as “resource limited settings”. Ironically, these regions have one of the 
world’s highest densities of population and are the ones most severely hit by
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the life threatening epidemics and diseases like Acquired Immune Deficiency Syndrome 
(AIDS), malaria and tuberculosis [1-3]. Illiteracy and lack of health and sanitation 
awareness leads to these diseases outbreak and consequently these people need to 
undergo diagnosis and monitoring tests at regular intervals to prevent a huge loss of 
human life. Extreme poverty and scarcity of basic infrastructure deprives these teeming 
millions of access to even primary healthcare facilities. With the intervention of global 
health agencies like the World Health Organization and non-governmental agencies like 
the Bill and Melinda Gates Foundation and several others, the hospitals and health clinics 
in these regions are equipped with state-of-the-art disease diagnostic and treatment 
systems [4-7]. However, a major proportion of the population in these regions resides in 
rural areas far from the urban health centers and hence, is unable to avail the benefits of 
these facilities. Consequently there is a major research emphasis on developing 
inexpensive healthcare devices and systems which can be used at the point-of-care (POC) 
in these resource-limited settings with a performance equivalent to the state-of-the-art 
systems and with minimal resource requirements [8, 9].        
 
Interestingly, the two different demographics described above with totally 
different economic and social frameworks have an identical requirement of POC 
diagnostic and monitoring systems for an efficient health and disease management. Rapid 
technology strides in the past few decades have made it possible to design and develop 
systems to meet this huge need for POC biomedical devices. Development of these 
devices has primarily entailed the miniaturization of macroscale equipments and 
processes in a compact design with low sample requirements, using minimal 
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infrastructure like electricity, water and refrigeration and operable without the help of a 
trained health personnel. Design of these POC systems involves the identification and 
development of:  
 A mechanism to manipulate the biological sample (blood, saliva, urine etc.) in order 
to isolate and capture the desired disease biomarker. 
 A mechanism for making a quantitative/qualitative measure of the biomarker to 
ascertain the disease occurrence/stage. 
 
In this thesis, we will discuss POC systems for the analysis of blood and its 
components which enable diagnosis and monitoring of a large number of diseases.  
 
1.2 Blood: a major disease biomarker 
Blood is one of the most common biological samples whose constituents are used 
for diagnosis and staging of a large number of diseases. Blood consists of three kinds of 
cells; red blood cells (RBCs), white blood cells (WBCs) and platelets contained in a fluid 
known as plasma (Figure 1.1) [10]. Blood is primarily composed of: 
 Plasma which makes more than half the volume of the blood (~55%) and consists of 
about 92% of water and a number of other proteins, ions and hormones.  
 RBCs also known as erythrocytes constitute 99% of all the blood cells and are 
responsible for delivery of oxygen to different parts of the body. These cells are 




Figure 1.1: A scanning electron microscope image of blood cells [adapted from the 
wikipedia website: http://en.wikipedia.org/wiki/White_blood_cell]. The doughnut shaped 
cells are the RBCs, the spherical shaped cells are the WBCs and the small disc-shaped 
cells are the platelets. 
________________________________________________________________________ 
 WBCs also known as leukocytes are divided into 6 subcategories: neutrophils, 
basophils, eosinophils, lymphocytes, monocytes and macrophages. WBCs are 
normally spherical in shape with their size ranging from 7 to 20 μm in diameter. 
These cells play an important role in defending the body against infections and hence 
constitute an important part of the body’s immune system. The total count of WBCs 
and the differential count of their subtypes is therefore an important indicator for a 
number of immunological diseases.  
 Platelets also known as thrombocytes are irregularly shaped blood cells which are 2-3 





In particular, WBCs or their subtypes constitute different aspects of human 
immune system and an increase or decrease in their count from the normal level usually 
indicates an immunological disorder [11]. WBCs and their subtype count is therefore an 
important measure for diagnosis and monitoring of immunological diseases like AIDS as 
well as other diseases like leukemia [12]. Patients afflicted with these diseases need to 
undergo WBC count tests (total as well as differential) at regular intervals (few days to 
months) to ascertain the efficacy and to accordingly modify the treatment regimen to 
check the proliferation of the disease. To summarize, WBC and their subtypes count tests 
constitute probably the most important tests for ascertaining the functioning of human 
immune system and hence are required to be conducted at frequent intervals to diagnose 
and stage an immunological disorder. It cannot be emphasized enough that a WBC and 
their subtypes counting system which can be used at the point-of-care (POC) will enable 
a more efficient disease management particularly in resource limited settings. Next, we 
review the current state-of-the-art techniques used for counting WBCs and their subtypes 
from human blood. 
 
1.2.1 Flow cytometry for counting WBCs and their subtypes 
 Current techniques for counting WBCs and their subtypes are based on flow 
cytometry (FC) which is considered the gold standard for quantifying WBCs with a 
relatively small margin of error [13]. The operation principle of FC involves the hydro-
dynamic focusing of cells which are registered to a counter while passing one by one 
through the focal point of a laser/detector setup. The interaction of the edge of cell with 
the laser light leads to forward light scatter whose magnitude indicates cell size. Light 
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photons interacting with the internal contents of a cell scatters at a wide angle and this 
side scatter provides information about the internal compostion (e.g. granularity) of a 
cell. A specialized type of flow cytometry, known as fluorescence activated cell sorting 
(FACS) is the most widely used method for counting individual cells (Figure 1.2) [14]. 
In this approach, the cells are labeled with a fluorescent dye which specifically tags the 
cells of interest. This dye gets excited by light in a certain wavelength range and emits 
light in another wavelength range. If a cell emits light upon passing through the focused 




Figure 1.2: Mechanism by which Fluorescence activated cell sorter (FACS) counts and 
sorts cells [adapted from http://classes.midlandstech.com, Copyright 2004 Pearson 
Education, Inc.].  
________________________________________________________________________ 
The state-of-the-art FC instrumentation consists of commercial available multi-
purpose FACS cytometers or specialized single platform flow cytometers designed for 
counting WBCs. These instruments are expensive ($30,000-$150,000) and not realistic 
options for most POC settings as they are bulky, have continuous electricity 
requirements, require the use of filtered water and expensive refrigerated reagents, and 
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require technical expertise for operation (Figure 1.3). Single-purpose FC designs have 
constraints similar to standard flow cytometry: costs, electricity dependence, and 
operational inefficiencies. For all of these reasons, the use of FC systems has been mostly 
limited to hospitals and specialized clinics in big cities; they are almost unaffordable for 
the small health centers and inaccessible to the people in the resource limited settings. 
These limitations of the FC systems bring forward a pressing need to develop 
inexpensive, portable systems which can be used at the POC for isolating and counting 
WBCs from human blood. 
 
Figure 1.3: Image of a two-laser FACS Calibur Flow Cytometer [adapted from 
http://www.georgiahealth.edu/cancer/shared/flow/equipment.html]. The flow cytometer 
is expensive, bulky, needs electricity and refrigerated reagents and a trained personnel for 
its operation and maintenance.   
________________________________________________________________________ 
 
1.3 Thesis Objective 
As discussed earlier, requirements of large volumes of samples and expensive 
reagents (in the order of ml), complicated and costly optical components and technical 
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personnel makes FC instruments unsuitable for the resource limited settings. Hence there 
is a pressing need to develop inexpensive portable WBC counting systems which can be 
used at the point of care in resource limited settings. We envision a WBC counting 
system similar in operation to a glucose level monitoring instrument (known as a 
glucometer) used by diabetic patients (Figure 1.4). In order to obtain the count of WBCs 
or their subtypes, an undiluted blood sample will be drawn from the patient using the 
standard finger-prick method and loaded by the user into a disposable biochip that will 
process the blood sample. The biochip will be inserted into the analysis module which 
will provide the WBC count in less than a minute. This system will enable to perform 
WBC count test for a few dollars and its portability and ease-of-use will make it suitable 
for the resource limited settings.  
 





In order to develop a compact WBC counting system, we envision a disposable 
biochip that can: a) capture WBCs from human blood and b) independently image and 
count the captured cells. The proposed biochip will be formed by integration of the 
microfluidic and microoptical devices respectively (Figure 1.5). The microfluidic 
component of the device will enable the capture of thousands of WBCs on the biochip 
surface and the microoptical component comprising of an array of microlenses will 
enable to image and count these cells. The incorporation of microoptical components on 
chip will preclude the need to use the conventional, bulky microscope elements resulting 
into a compact and cheaper WBC counting system.  
 
Figure 1.5: Disposable WBC capturing biochip obtained by the integration of 
microfluidic (cell capturing) and microoptics (cell imaging) components.  
________________________________________________________________________ 
The biochip’s cell trapping and imaging components have been presented in a 
cross sectional view (Figure 1.6). The first (microfluidic) module of the biochip is 
responsible for the capture of WBCs from the blood sample and the optical excitation of 
fluorescent molecules attached to the cell surfaces. The second (microoptics) module of 
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the biochip is responsible for collecting the light emitted by the captured WBCs and 
forming their image on an imaging sensor. The data analysis module would analyze this 
image and the number of captured WBCs will be obtained.  
 
Figure 1.6: Cross-sectional schematic of the WBC counting biochip.   
________________________________________________________________________ 
The biochip would be simple to operate, inexpensive to fabricate and will have 
low sample and reagent requirements (in the order of μl). In this thesis, we employ lab-
on-chip technology for developing microfluidic and microoptical modules to fabricate the 
proposed WBC counting biochip. 
 
1.3.1 Microfluidics for lab-on-a-chip systems 
 Microfluidics is a relatively recent branch of science and engineering which deals 
with the control and manipulation of fluids in flow channels with sub-mm dimensions 
[15]. Typically, such flow channels have at least one dimension (mostly the height) in the 
order of a few to a hundred microns. Microfluidics has favored greatly from the 
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advancements in the planar microfabrication technologies used for producing integrated 
semiconductor devices and microelectomechanical systems (MEMS) based sensors and 
actuators [16]. Over the past two decades, there have been pioneering developments in 
the field of microfluidics which enabled the integration of flow control modules like 
pumps, valves, mixers etc. on the microfluidic devices, hence making these systems 
compact and inexpensive by eliminating the need for external equipment to perform these 
functions [17].  
 
 Lab-on-a-chip devices refer to a class of devices which enable performing a set of 
laboratory operations (chemical and biological) on a small scale [18]. These devices are 
compact, easy to use, have lesser sample and reagent consumption as well as a smaller 
process time, enable precise control of the biological and/or chemical interactions and are 
very cost effective. Microfluidic devices possess all the characteristics mentioned above 
and hence the development of lab-on-a-chip systems has been concurrent with the 
advancement in microfluidic technology. Microfluidic systems have emerged with wide 
range of applications like individual molecule investigation [19], optofluidic systems 
integrating microfluidics with optics [20], chemical reaction on chips [21], cell 
manipulation on chips [22] and point-of-care diagnostic systems [23].      
 
1.3.2 Research goals 
With the characteristics mentioned above, lab-on-a-chip technology presents itself 
as a promising alternative for the miniaturization of conventional state-of-the-art flow 
cytometers. These microdevices will meet the demand for point-of-care disease 
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diagnostic and monitoring systems. Using microfluidic technology as the enabling tool, 
this thesis aims towards developing components for the point-of-care WBC capture and 
counting biochip. The thesis aims at achieving the following objectives: 
1. To develop a cell trapping microfluidic biochip for capturing and counting white 
blood cells from human blood.  
Since the white blood cells constitute a very small fraction of total cellular 
composition of the blood, separation of WBCs from the other cells (RBCs and platelets) 
is the first step in the process to count the WBCs and their subtypes. The conventional 
flow cytometry systems used for counting WBCs employ a serial process in which the 
fluorescently marked WBCs (in a human whole blood sample) are passed in a focused 
stream through a detection region and are counted and separated based on their light 
scattering characteristics. Miniaturizing these systems into portable setups however, 
entails expensive optical components (lasers, detectors etc) which need to be precisely 
aligned to perform a serial counting of the WBCs. Here, we aim to develop a microfluidic 
cell trapping biochip which will perform a size based separation of the WBCs from 
human whole blood. This approach will entail a parallel cell counting process in which 
thousands of WBCs will be simultaneously captured on the surface of the biochip and 
counted. This biochip should be simple to use, perform an efficient capture of the WBCs, 
integrable with other optical components and provide a generic platform for size based 
capture and counting of cell types other than blood cells for diagnosis and monitoring of 




2. To develop a micro-optical module for simultaneously imaging a large number of 
cells.  
Optical imaging is the most commonly used technique for analysis of biological 
samples (cells, tissues etc). A conventional microscopy setup uses a high magnification 
objective lens with a high light collection capability (indicated by its numerical aperture 
NA) to obtain a high-resolution image of the micron-sized cells. However these objective 
lenses are not only expensive, they also have a small field of view (FOV) (a 20x 
magnification objective has a FOV of ~ 1mm), which prevents them from simultaneously 
imaging cells spread over a larger area. Since our aim is to develop a system that can 
simultaneously count thousands of WBCs captured on the biochip surface (Aim 1), we 
work towards development of optical systems that can provide a high FOV imaging 
capability while retaining the optical performance (resolution, magnification etc) of the 
microscope objective lenses. Here, we aim to develop two types of inexpensive microlens 
arrays which enable simultaneous counting of a large number of microobjects spread over 
a large field of view (in the order of cm). The first types of microlenses are polymer-
based microlenses that can be fabricated easily and reproducibly from a patterned mold 
and have an equivalent optical performance as the microscope objective typically used 
for imaging cells and tissues. The second type of microlenses are doublet microlenses 
which have a higher light collecting performance (NA) than the planar microlenses and 
are capable of forming brightfield as well as fluorescent images of biological 
microobjects directly on an imaging sensor surface. These microlens arrays can be 
integrated with the cell trapping biochip described above and could possibly enable 
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development of inexpensive systems for on-chip counting of cells, precluding the need 
for bulky external microscopes.   
    
1.4 Thesis Organization 
The research work presented in this thesis has been organized in the form of the 
following five chapters: 
Chapter 2 – Literature Review 
 This chapter reviews the microfluidic lab-on-chip devices for capturing and 
counting white blood cells (WBCs) and their subtypes. A review of various microlens 
arrays with an emphasis on their microfabrication processes and optical performance has 
also been discussed in this chapter.   
 
Chapter 3 – A 3D Microfluidic Cell Trapping Biochip For Counting White Blood Cells 
 This chapter presents a novel 3D cell trapping biochip which enables size based 
confinement and capture of WBCs. The biochip is a significant improvement over the 
membrane based captures approaches in that it confines WBCs in the 3 dimensions 
resulting into higher WBC trapping efficiency. The design of the biochip has been 
optimized to ensure equal WBC trapping in all regions of the biochip without any 
dependence upon the relative distance from the biochip inlet or outlet. A high (>87%) 
WBC trapping efficiency has been demonstrated using the biochip.   
 




This chapter presents a soft lithography based approach to fabricate an array of 
planar, polymer-based microlenses. UV-assisted curing of a pressurized polymer under 
deformable, elastomeric membranes is utilized to obtain fixed focal length microlenses. 
Sub-100 μm diameter microlenses with numerical aperture (NA) in the range 0.05-0.30 
have been fabricated using this approach. We utilized the microlenses to image the 
micron-size resolution features patterned on a chrome mask.   
 
Chapter 5 – A High Numerical Aperture Doublet Microlens Array  
This chapter demonstrates a novel doublet microlens array fabrication technique. 
The doublet microlenses are formed using glass microspheres assembled on silicon 
microholes and planarized using a polymer layer. The fabrication process was 
combination of silicon microfabrication and a novel fluidic assembly technique. The 
fabricated microlenses had a numerical aperture of 0.5 which was a significant 
improvement over the NA (0.3) of microlenses reported in Chapter 4. These microlenses 
could also perform brightfield as well as fluorescent image formation of micron-size 
objects directly on an imaging sensor without the use of intermediate lenses.  
 
Chapter 6 – Conclusions and Future work 
 This chapter summarizes the work demonstrated in this thesis and presents the 






 This chapter presents a review of the microfluidic biochips that have been 
designed for capturing and counting white blood cells (WBCs) from human blood. A 
review of various microlens arrays, which can be utilized for on-chip optical imaging of 
microobjects, has also been presented in this chapter.  
 
2.1  Introduction 
Microfluidic lab-on-chip technology has found extensive applications in the 
global healthcare sector for the past two decades [23, 24]. With their advantages of low 
sample requirements and reagent consumption, inexpensiveness and ease of operation, 
these devices have emerged as viable replacements to the macroscale flow cytometry 
(FC) techniques particularly for the point-of-care (POC) diagnostic applications. Since 
WBC count is an important biomarker for the diagnosis and monitoring of a number of 
immunological diseases and disorders, significant research emphasis has been given 
towards the development of microfluidic devices for WBC capture and counting. The 
WBC capture microdevices employ various principles like size based capture, 
immunoaffinity based capture etc. In the first section of this chapter, various microfluidic 
approaches for WBC capture from human blood are discussed. 
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Since this thesis also presents microlens arrays for high-resolution optical imaging of 
micron-sized objects, we review the fabrication and optical performance of various 
microlens arrays.   
 
2.2 Microfluidic biochips for WBC capture and enumeration  
 WBCs and their subtypes count is an important diagnostic and monitoring 
indicator for a number of immunological diseases (e.g. AIDS). For most of these 
diseases, a specific WBC subtype count is required to make a disease assessment (e.g. 
CD4+ T-lymphocyte count to monitor HIV/AIDS proliferation). A strategy to count these 
WBC subtypes can entail capture of all the WBCs and then identifying and counting the 
targeted WBC subtype by performing an additional step. A large number of microfluidic 
biochips have been proposed for separation and capture of WBCs (and their subtypes) 
from human blood [25]. Since one of the aims of this thesis is to develop a WBC 
capturing microdevice, we are going to review these microfluidic approached to capture 
WBCs. Even though some of these microdevices were designed to capture a specific 
WBC subtype (rather than all the WBCs), their operating principle can be used for 
capturing all the WBCs. 
 
2.2.1    Size-based capture of WBCs 
 Since WBCs are bigger in size than other blood cells (RBCs and platelets), they 
can be separated from these cells by passing human blood through filter structures which 
allow RBCs, platelets and blood plasma to pass through while capturing larger WBCs. In 
one such approach, a commercial polycarbonate track-etch membrane filter (with ~ 3 μm 
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in diameter pores) is used to separate and capture WBCs from human whole blood 
(Figure 2.1) [26]. The smaller and less stiff RBCs and platelets squeeze through the holes 
while the larger WBCs are captured. This device was designed to count the CD4+ T-cells 
(a type of WBCs) for ascertaining the proliferation of HIV infection in infected patients. 
The T-cells were stained with fluorescent antibodies before the whole blood was injected 
into the device and the captured T-cells were enumerated with the help of epifluorescence 
microscopy. This is an extremely simple approach for WBC capture requiring no sample 
preparation and a process time of less than 10 minutes. However it can be seen that some 
of the membrane holes are fused leading to the escape of WBCs along with the RBCs and 
platelets and resulting into a low efficiency of capture of WBCs.  
  
Figure 2.1: The membrane flow cell device for counting CD4+ T-lymphocytes from 
human blood [adapted from [26]]. (A) Upon processing the whole blood through the flow 
cell, the white blood cells are captured on the micro holes and the red blood cells and 
platelets filter through. The arrows indicate the red blood cells filtering through the 
microholes. (B) Fluorescence image showing T-lymphocytes (stained with fluorescent 
antibodies) captured on the membrane.    
________________________________________________________________________ 
 A WBC capture approach similar to that employed in the membrane filtration 
device used different patterns of microfilters etched on a silicon substrate (Figure 2.2) 
[27]. The various designs used were a) weir, b) pillar, c) crossflow and d) membrane. 
While the RBCs squeezed through the 3.5 μm filter patterns, the WBCs were captured. 




efficiencies. While the weir pattern device obtained a WBC trapping efficiency and RBC 
passing efficiency of 70% and 28-42% respectively, the crossflow device was the most 
efficient pattern with the WBC trapping efficiency and RBC passing efficiency of 72-
95% and 60-95% respectively. Since the RBCs are almost two to three orders of 
magnitude more in number than the WBCs, even a small percentage (5%) of non-passing 
RBCs will clog the device. These filtration based WBC capture approaches suffer from 
the drawback that they trap WBCs in 2 dimensions and the cells being flexible, are free to 
squeeze out in the 3
rd
 dimension resulting into a lower WBC trapping efficiency.     
 
Figure 2.2: Schematic representation of the silicon microfilter designs used for WBC 
capture [adapted from [27]]. The designs are a) weir filter (side view), b) pillar filter (top 










2.2.2    Immunoaffinity based capture of WBCs 
 Many human cells express unique receptors on their cell surface (antigens) which 
bind to specific proteins (known as antibodies extracted from blood serum of humans, 
mouse etc.). All WBC subtypes have a common cell surface receptor CD45, which can 
be used for isolating WBCs from other blood cells (RBCs and platelets) by using a 
monoclonal antibody against this receptor (anti-CD45 monoclonal antibody). Also 
different subtypes of WBCs possess a unique combination of different cell surface 
receptors like CD3, CD4, CD8, CD18 etc. By using antibodies specific to a particular 
receptor, it is possible to capture and separate a WBC subtype from other WBCs. 
Capturing WBCs by passing blood over a surface functionalized with antibodies is a very 
useful WBC isolation approach. This immunocapture approach becomes more powerful 
in a microfluidic device which with its high surface area to volume ratio enables greater 
cell-antibody interactions resulting into a higher WBC trapping efficiency.  
 
   Immunoaffinity based microfluidic devices have been used to capture WBCs 
from human blood using two different approaches. These approaches are: a) WBC 
adhesion on antibody functionalized structures (pillars) in a microfluidic device and b) 
Optimization of shear stress for WBC adhesion on antibody immobilized planar surfaces. 
The first approach mimics a physiological process in which the blood vessels express 
specific adhesion proteins on their surface to selectively capture WBCs, hence separating 
them from RBCs and platelets [28, 29]. In this phenomenon, the cells are not 
permanently immobilized on the binding site instead they roll on the surface. 
Microfluidic devices with different pillar geometries and configurations, functionalized 
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with a WBC specific adhesion protein (human E-selectin IgG) were used to capture 
different WBC cell lines and the influence of pillar geometry and configuration on the 
speed and efficiency of WBC capture was evaluated (Figure 2.3). Using this device, a 
hundred fold enrichment of the WBCs was obtained as compared to their original 
concentration. However, since these experiments were done with leukocyte cell lines 
rather than human blood sample, the capability of this approach to separate and capture 
WBCs from other blood cells in the sample is still unknown.  
 
Figure 2.3: Microfluidic device with protein (E-selectin) functionalized pillars for 
capturing leukocyte cell lines [adapted from [28]]. (A) Square array of 25x25 μm square 
posts spaced 25 μm apart. (B) Alternating arrays of thin posts with 30 μm longitudinal 
post to post spacing and the adjacent rows offset by 15 μm in the flow direction.   
________________________________________________________________________ 
The second immunoaffinity based capture approach relies upon the change in the 
cell-antibody adhesion mechanics with the shear stress in the flow. Different WBC 
subtypes have different optimal shear stress values for the most efficient capture. To 
ascertain the optimal shear stress for the adhesion of human lymphocytes, cells were 
flown in a device (with antibody functionalized surface) with linearly varying shear stress 
[30]. Once optimized, devices with parallel flow design (constant optimal shear stress 




100% and 75% pure suspensions of T-lymphocytes and B-lymphocytes were obtained in 
~ 3 min.  
 
 Using the above immunoaffinity based capture approach, a microfluidic device 
was fabricated for capturing and counting of CD4+ T-cells from 10 μl of HIV infected 
whole blood (Figure 2.4) [32]. A T-cell capture efficiency of 70-80% and a capture 
specificity of 60-90% were obtained using this device. A low value of capture specificity 
was attributed to the binding of monocytes on the antibody-immobilized surfaces. 
 
Figure 2.4: Microfluidic device used for capturing and counting CD4+ T-cells from 
human whole blood [adapted from [32]]. (A) Schematic of the steps of operation of the 
CD4+ T-cells counting microdevice. (B) Microfabricated device with optimal channel 
dimensions (4 mm x 51 mm x 50 μm for optimal shear stress) to capture T-lymphocytes.    
________________________________________________________________________  
 A modified version of the above microfluidic device was designed to minimize 
the monocyte contamination to improve the CD4+ T-cell capture purity [33]. In this 
design, a monocyte depletion chamber was incorporated upstream of the CD4+ T-cell 
capture chamber (Figure 2.5). The monocytes with a higher optimal shear stress value 
(1.5 dyn/cm
2
) were captured in the depletion chamber whereas the CD4+ T-cells with a 
lower optimal shear stress value (0.3 dyn/cm
2




chamber.  Using these devices, the T-cell capture purity increased to 80-90%. Although 
these devices were designed specifically for the capture of CD4+ T-cells, they can be 
functionalized with a suitable antibody to capture any leukocyte of interest. However, 
these devices have a drawback that their functionalization comprises of a number of steps 
and non specific binding of other blood cells significantly brings down the captured cell 
purity.               
 
Figure 2.5: Schematic representation of a two stage cascaded device for CD4+ T-cell 
capture [adapted from [33]]. Reduced monocyte contamination results into an increased 
T-cell capture purity.   
________________________________________________________________________ 
 
2.3 Microlens arrays for imaging micron-sized biological objects 
Optical imaging based approaches have conventionally been used for detecting 
and visualizing micron-scale biological objects like cells and tissues. An optical 
microscope is the instrument most commonly used for cellular imaging. Various variants 
of the optical microscopy techniques like fluorescence microscopy, confocal microscopy 
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and multiphoton microscopy are used for cellular imaging depending upon the optical 
performance desired like the resolution, magnification, selectivity etc. These microscopes 
provide high resolution cellular imaging enabled by the high light collecting capability of 
their objective lenses (indicated by their numerical aperture NA). However, these high 
NA objective lenses have a small field of view (FOV) (in the order of 100-1000 μm) that 
prevents simultaneous imaging of cells and tissues spread over a larger area (in the order 
of mm). Also, the large size and huge cost of these objective lenses make them unsuitable 
for point-of-care imaging applications.       
 
 Advancements in the microfabrication technology over the past two decades has 
enabled researchers to develop micron scale lenses also known as ‘microlenses’ which 
aim to mimic the optical performance of conventional objective lenses. These microlenes 
are often obtained using a batch fabrication process from a photolithographically 
patterned mold. This enables simultaneous fabrication of thousands of microlenses 
reproducibly at a very low cost. Also, arrays of these microlenses enable simultaneous 
imaging of micro-objects spread over a large area, providing large FOV imaging 
capability. In the next section, we will review these microlens facbrication techniques 
with emphasis on the optical performance as well as the ease of fabrication of these 
microlenses.  
 
2.3.1    Microlens fabrication methods 
 The microlenses can be divided broadly into two categories, i) fixed focal length 
microlenses and ii) variable focal length (tunable) microlenses. The tunable microlenses 
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primarily comprise of micro-optofluidic lenses that use a liquid as the lens medium and 
use a microfluidic scheme for actuating the fluid to vary the microlens focal length. 
Tuning using pneumatic pressure, dielectrophoresis, stimuli responsive hydrogels, 
electrowetting and hydrodynamic forces respectively are some of the actuation 
techniques used for varying the microlens focal length [34]. Although these techniques 
enable microlenses with focal lengths in a wide range, they require an external actuation 
source and hence they are not suitable for point of care applications with infrastructure 
constraints. Thus in this review, we will focus on the fabrication techniques for fixed 
focal length microlenses.    
 
2.3.1.1  Fixed focal length microlenses 
 One of the earliest methods for fabrication of the fixed focal length microlenses 
involved melting and reflow of photoresist microstructures on a glass substrate. In order 
to obtain these microlenses, the photoresist microstructures were melted by heating them 
to a temperature of 150ºC. The surface tension caused the melted photoresist to obtain a 
curved microlens profile (Figure 2.6A) [35]. This fabrication approach provides high fill 
factor for the microlenses, with the microlens pitch (center-to-center distance) being as 
small as the microlens diameter (Figure 2.6B) [36]. The surface profile of these 




     
Figure 2.6: Scanning electron micrographs of the microlenses fabricated using 
photoresist melting and reflow methods. (A) 1.5 µm in diameter microlenses can be 
fabricated using this approach [adapted from [35]]. (B) High fill factor square microlens 
array fabricated using photoresist melt and reflow method [adapted from [36]].  
________________________________________________________________________ 
 
 Ink-jet printing of ultraviolet (UV) curable polymers has also been employed to 
obtain refractive microlenses. This process utilizes a drop-on-demand ink-jet printer to 
dispense the polymer on a hydrophobic substrate (Figure 2.7A) [37]. The polymer 
droplets are subsequently polymerized into plano-convex microlenses using UV light 
irradiation (Figure 2.7B) [38]. Like the photoresist reflow based fabrication approach, 
this process too enables fabrication of microlens arrays with a high fill factor. However 
this process requires the use of a very expensive setup for dispensing polymer on the 
substrate. Also the surface profile of the microlens depends greatly upon the surface 









   
           
 
Figure 2.7: Ink-jet printing process for fabricating microlenses. (A) Schematic of the ink-
jet printing setup for dispensing UV curable polymer [adapted from [37]]. (B) 
Microscopic image of an array of ink-jet printed microlenses [adapted from [38]].   
________________________________________________________________________ 
Focused ion beam milling and femtosecond laser direct writing techniques have 
been proposed for fabrication of high NA microlenses [39, 40]. While the focused ion 
beam milled microlenses achieved NA of 0.64, microlens fabricated using femtosecond 
laser direct writing technique achieved high NA of 0.46 for a 100% fill factor (Figure 
2.8). Like ink-jet printing technique, these processes are serial processes and require 




     
Figure 2.8: (A) Scanning electron microscope (SEM) image of the microlens fabricated 
using focused ion beam milling [adapted from [39]]. (B) SEM image of hexagonal 
microlens array fabricated using femtosecond laser direct writing. A 100% microlens fill 
factor is obtained using this technique [adapted from [40]].  
________________________________________________________________________ 
 
 A simple microlens fabrication approach involves molding various materials 
against rigid and elastomeric molds [41-44] (Figure 2.9). The patterns on a mold form 
the negative replica of the microlens profile resulting into microlenses when a thermally 
or UV curable polymer is cast on the mold. This microlens fabrication approach is a 
parallel approach which results into an array of 100s and 1000s of microlenses at the end 
of one molding step. This microlens fabrication process is simple to implement, however 
the quality of the mold deteriorates with its greater usage resulting into poor microlens 









       
 
                
 
Figure 2.9: Microlens fabricated by molding various materials against the elastomer 
(polydimethylsiloxane PDMS) and silicon molds respectively. (A) Schematic of the 
fabrication of sol-gel glass microlens arrays by molding them against the PDMS mold 
[adapted from [42]]. (B) SEM image of sol-gel glass microlenses [adapted from [42]]. 
(C) Microlens mold obtained by the isotropic wet etching of silicon in an acid solution 
[adapted from [44]]. (D) SEM image of an array of microlenses obtained by molding a 
UV curable polymer against the isotropically etched silicon mold [adapted from [44]].  
________________________________________________________________________ 
A                                                      C                                                        




 This chapter reviewed various microfluidic devices for separating and capturing 
WBCs and their subtypes. Various microfabrication techniques for obtaining high 
performance fixed focal length microlens arrays were also reviewed in this chapter. The 
advancements in the fields of microfabrication and microfluidics technology has led to 
the miniaturization of macroscale cell separation and imaging processes. An integration 
of these two technologies can enable the development of compact and cheap point-of-
















A 3D Microfluidic Cell Trapping Biochip For Counting White Blood Cells 
 
In this chapter, we present a microfluidic biochip for trapping and counting 
human white blood cells on a microfabricated hole array. A novel 3D cell trapping 
architecture has been proposed for performing size based capture of the white blood cells. 
White blood cells suspended in the buffer solution were injected under pressure into the 
biochip and optimal pressure for the highest cell trapping efficiency was ascertained. 3 
psi was measured as the optimal injection pressure at which a high (>87%) efficiency of 
trapping of the white blood cells was achieved. We aim to develop this device as a point-
of-care diagnostic and monitoring platform that can perform size based separation and 
counting of white blood cells and other disease indicators like the circulating tumor cells 
from human whole blood.     
 
3.1 Introduction 
White blood cells (WBCs) and their subtypes are important constituents of the 
human immune system [45]. Their concentration, quantified by a WBC count test, 
indicates the state of body’s defense against potentially harmful pathogens such as 
bacteria, viruses, and fungi [46]. In addition, an abnormal WBC count (which 
corresponds to a WBC concentration of >10,000 cells/μl or <4,000 cells/μl of whole 
blood), may be associated with certain hematologic malignancies [47, 48], autoimmune 
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disorders [49, 50] or even drug toxicities [51-53]. WBC counts test are therefore 
important diagnostic tools for a number of human diseases and disorders, as well as for 
monitoring the progression and treatment of such pathological conditions. 
 
Flow cytometry (FC) is the current gold standard for counting WBCs [54]. 
Although FC instruments have high throughput capacity and accuracy, they are expensive 
(tens of thousands of dollars), non-portable, consume large volumes (typically in the 
milliliter range) of blood samples and reagents and require considerable technical 
expertise for their operation and maintenance. Their use is therefore limited to hospitals 
and specialized clinics in big cities and renders them unsuitable in the field, at the 
doctor’s office or in small communities that lack both the infrastructure as well as the 
trained health personnel. 
 
To overcome those issues, microfluidic technology has recently emerged as an 
alternative approach for replacing the bulky and expensive FC instruments. Due to the 
unique advantages of small volume sample and reagent consumption, low cost and ease 
of operation, various microfluidic devices have been developed to address the challenge 
of WBC (or their subtypes) count on-chip. Such microfluidic devices can be divided into 
two categories: continuous flow microdevices [55-60] and cell-capturing microdevices 
[25]. The former ones can be considered as miniaturized FC systems as cells are counted 
as they flow through the detection region. However, these devices have to be precisely 
interfaced and aligned with elaborate and bulky fluidic, optical and electrical setups for 
registering the cells of interest. 
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In cell-capturing microdevices, cells are mechanically or chemically immobilized 
on-chip and imaged/counted using a microscope and a CCD camera. Mechanical 
immobilization approaches typically employ a commercial membrane filter with micron-
sized holes for capturing WBCs from whole blood [26]. The membrane filter also 
functions as a cell separator: WBCs, being larger in size than the red blood cells (RBCs), 
are captured in the holes while the RBCs squeeze through the holes. However, the holes 
do not have a consistent shape and size, as a result some holes are fused together leading 
to the escape of WBCs and low WBC trapping efficiency. Microfabricated silicon-based 
microfilters have also been proposed for isolating WBCs from human whole blood [27]. 
These microfilter based devices essentially have a 2D architecture and they capture 
WBCs through their confinement in a plane. However the cells have the freedom to move 
in the third dimension leading to their escape and a reduced (72-85%) trapping efficiency.      
 
Chemical immobilization through immunoaffinity-based selection has also been 
used for capturing WBCs and their subtypes (e.g. CD4
+
 T-cells). The working principle is 
straightforward: blood samples flow through a microfluidic device that has previously 
been functionalized with antibodies against the desired cell surface receptors. In this 
approach, enumeration of the captured cells is done optically using a microscope [32, 33, 
61] or electrically by measuring the impedance change upon cell lysis using on-chip 
electrodes [62]. Functionalization of those microdevices requires a number of incubation 
and washing steps while non-specific antibody binding reduces the purity of the 
functionalized cell population. 
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HemoCue WBC is a benchtop WBC counting system that does not use 
microfluidic technology [63]. The system counts WBC concentration in human whole 
blood by imaging of the stained nuclei of WBCs. This system, although simple to use, is 
not accurate (accuracy <90%) and is not able to distinguish nucleated RBCs from WBCs 
while it measures the average light intensity from the bulk of the lysed blood sample.  
    
In this work, we describe a cell-capturing microfluidic chip that mechanically 
traps human WBCs. The microdevice incorporates a novel 3D architecture in which an 
array of microholes (termed ‘microhole array’) is microfabricated on a suspended, thin 
film that is sandwiched between a two-layer microfluidic network. The proposed device 
differs from previous membrane-type cell-capturing approaches as it confines WBCs in 
all the 3 dimensions (a simple membrane confines cells only in 2 dimensions) leading to 
a high WBC trapping efficiency (>87%). Similar to other cell-capturing devices, the 3D 
architecture also provides an advantage over flow cytometry approaches as thousands of 
on-chip trapped WBCs can be imaged/counted simultaneously using standard fluorescent 
microscopy This precludes the need for precise alignment of optical elements with the 
microfluidic chip. Although we report results from lysed human blood samples, our 
microfluidic chip due to its unique two-layer architecture can potentially perform size-
based separation of RBCs and platelets from WBCs. We envision the integration of this 
microdevice with on-chip optical modules and its subsequent development into a generic 
platform for size-based separation and imaging/counting of different types of cells for 




3.2 Materials and methods  
3.2.1    Materials 
SU-8 photoresist was purchased from MicroChem (Newton, MA) and the 
polydimethylsiloxane (PDMS) elastomer was obtained from Dow Corning (Midland, 
MI). Chlorotrimethylsilane was purchased from Sigma Aldrich (St. Louis, MO). 
Phosphate buffered saline (PBS) was obtained from Mediatech, Inc (Manassas, VA). 
RBC lysis buffer was obtained from eBioscience (San Diego, CA). Alexa Fluor® 488-
conjugated mouse antibody to human CD45 (AF488-anti-CD45) was purchased from 
Invitrogen (Frederick, MD).  
 
3.2.2    Biochip design 
Our 3D cell-capturing chip (Figure 3.1) consists of a membrane of ~10,700 
microholes, ~4 µm in diameter that are patterned on a 1 μm thick silicon nitride film. The 
microholes are arranged in a 17x17 array of clusters (289 clusters in total). Each cluster 
contains 37 microholes and it is separated from its neighboring ones by a distance of 120 
μm. The entire microhole array is ~2 mm x 2 mm and it is sandwiched between two 
microfluidic networks. The top microfluidic network includes: (i) an inlet region that 
branches into 17 microfluidic channels (termed ‘inlet fluidic arms’) and (ii) 18 
microfluidic channels (termed ‘outlet fluidic arms’) that merge into the outlet region. 
Each inlet fluidic arm is a 60 µm wide, 20 µm deep, dead-end microchannel that delivers 
WBCs to a single row of clusters (each row contains 17 clusters). The outlet fluidic arms 
are 26 µm wide, 20 µm thick, dead-end microchannels that are connected to the inlet 
fluidic arms through the bottom microfluidic network. The bottom microfluidic network 
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consists of 30 µm long, 1.28 µm thick microchannels (termed ‘microfluidic connectors’) 
that connect the clusters from a single inlet fluidic arm to two outlet fluidic arms through 
a set of 4 µm in diameter microholes (termed ‘exit microholes’).  
 
 
Figure 3.1: (A) 3D illustration of a WBC trapping microhole cluster of the biochip. The 
cell trapping layer is sandwiched between the top and the bottom microfluidic channels 
(Top cover is not shown for clarity). (B) A snapshot of the microfluidic biochip (12 
images were obtained with a 5x microscope objective and stitched together). Enlarged 
view of the trapping holes with the top microfluidic channels was obtained using a 20x 
microscope objective. A magnified view of an individual microhole cluster (obtained 




The working principle of the biochip is purely based on mechanical confinement 
(Figure 3.2): WBCs, due to their large size (7-15 µm in diameter), are spatially restricted 
and therefore immobilized in the 3 dimensional space that is created by the microhole 
array and the thin (~1.28 µm thick) bottom microfluidic network. While WBCs are being 
trapped in the microhole array, the remaining blood continues to flow through the 
microholes, the bottom microfluidic network and the outlet microchannel of the top 
microfluidic network. After the entire blood sample is processed, the number of trapped 
WBCs is counted by examining the microhole array under a fluorescent microscope.  
 
Figure 3.2: Schematic of the trapping of WBCs in the microhole array. Fluorescently 
tagged WBCs suspended in the buffer solution are injected into the biochip under 
pressure. While the buffer flows through the microhole array, the WBCs are confined and 
trapped in the microhole array and their squeezing out is prevented by the bottom 




3.2.3    Biochip microfabrication 
The biochip consists of two microfabricated modules: the cell trapping module 
and the sample delivery module (Figure 3.3). The microfabrication of the trapping 
module starts with a low pressure chemical vapor deposition (LPCVD) of a silicon 
dioxide and a low stress silicon nitride layer (1.28 µm and 1 µm thick respectively) on a 
silicon substrate. The microhole array is then patterned on the silicon nitride layer using 
photolithography and reactive ion etching (RIE). An isotropic, HF time-etch step of the 
underlying silicon oxide layer is finally performed to obtain the microhole array and the 
bottom microfluidic network. The sample delivery module consists of a network of 
PDMS microfluidic channels fabricated using soft lithography. A 20 µm thick layer of 
SU-8 photoresist is spun and photolithographically patterned on a silicon wafer to obtain 
the microfluidic mold. PDMS is then cast on the SU-8 mold, cured at 65ºC for 2h and 
peeled off to obtain the sample delivery module. Silanization of the SU-8 mold prior to 
PDMS casting minimizes stiction of the cured PDMS. Holes are punched into the PDMS 
mold with a sharpened 19-gauge needle to obtain the inlet and outlet ports. Finally the 
silicon nitride and the PDMS surfaces of the two modules are exposed to air plasma (120 






Figure 3.3: The microfabrication process of the cell trapping biochip. The cell trapping 
and the sample delivery modules are fabricated separately and subsequently aligned and 
bonded under an upright microscope using a 5x microscope objective.  
________________________________________________________________________ 
 
3.2.4    Fluid flow simulations and modeling 
Parameters of the fluid flow through the biochip (pressure, volumetric flow rate 
and microfluidic resistance) were obtained using a combination of numerical 
(computational fluid dynamics (CFD)) and resistive electrical circuit modeling [65]. The 
top and bottom microfluidic networks were modeled using electrical circuit elements 
while the clusters were modeled using COMSOL. All microchannels in the two networks 
were represented as ohmic resistors with zero capacitance. The simulations were 
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performed in LT Spice IV software assuming that there are no WBCs present in the 
microhole array. Assuming rectangular geometry, the resistance (R) for each microfluidic 
segment (inlet and outlet fluidic arms, microfluidic connectors) was estimated by [66]: 
                                                 
where l, w and h are the length, width and height of the rectangular microfluidic segment 
respectively and η is the viscosity of the fluid (we used the viscosity of water (η = 10
-3 
Pa-s) in our calculations). 
 
The microfluidic resistance of a single cluster (Rcluster) was estimated in COMSOL 
using the laminar flow module. In those simulations, the fluidic resistance of a single 
microhole (Rmicrohole) was calculated by dividing the pressure drop across it by the 
volumetric flow rate through it. Subsequently, the microfluidic resistance of an entire 
cluster (Rcluster) was obtained by considering that all 37 microholes in the cluster are 
ohmic resistors connected in parallel (Rcluster = Rmicrohole / 37).  
 
3.2.5 Blood sample preparation and biochip operation  
All experiments were performed with lysed human blood samples. 20 µl of 
finger-prick human whole blood samples were initially tagged with monoclonal CD45 
fluorescent antibodies (Alexa Fluor® 488-anti-CD45, excitation 495 nm, emission 519 
nm, Invitrogen Inc.) in the ratio 10:3 (to label all the WBCs). Subsequently, the red blood 
cells (RBCs) were removed by incubating the blood sample with a lysis buffer 
(eBioscience, San Diego, CA) for 10-15 min. The WBCs were then collected via 
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centrifugation and finally diluted in PBS buffer (1x Dulbecco’s Phosphate Buffered 
Saline) to a total volume of 20 µl. 1 µl aliquots of this buffer solution (containing WBCs) 
were subsequently used for experiments.  
 
At the beginning of every experiment and before loading the blood sample, a 
purging step with PBS buffer was performed to remove air bubbles from the biochip and 
to ensure uniform flow conditions. All experiments were performed under constant 
pressure in order to eliminate WBC escape and/or rupture due to pressure buildup during 
the WBC trapping process. That was achieved by connecting the inlet of the biochip to a 
compressed air supply through a digital pressure controller (model number PC-30PSIG-
D/5P, Alicat Scientific, Inc.). The outlet of the biochip was exposed to the atmospheric 
pressure. 
 
3.2.6 WBC counting 
Fluorescently tagged WBCs were counted in the inlet region, the cell trapping 
array and the outlet region of the biochip using an upright epi-fluorescent microscope 
equipped with a low-light CCD camera (QuantEM: 512SC, Photometrics Inc.). The WBC 
number in the inlet region and the cell trapping array was obtained by analyzing images 
from those regions at the end of each experiment (e.g. when 1 µl of lysed blood sample 
was processed through the biochip). The fluorescent images were analyzed using 
commercial imaging software (MetaMorph, Molecular Devices Inc.). Fluorescent 
impurities (e.g. residuals formed during lysing, dust particles, etc) that could alter the 
WBC count, were eliminated by comparing their size and fluorescence intensity with the 
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average size and fluorescent intensity of manually-identified WBCs. WBCs that exited 
the cell trapping array were manually counted on the fly by continuously monitoring the 
flow through the outlet region of the biochip.  
 
3.3 Results 
3.3.1 Uniform pressure and flow rate distribution in the biochip  
We performed CFD simulations using COMSOL software to obtain the maximum 
pressure difference across the 37 microholes of a single cluster for different trapping 
scenarios. The maximum pressure difference across the microholes determines the 
tendency of an incoming cell to remain trapped or squeeze out. It is therefore an 
important parameter that affects the trapping efficiency. We varied the number of WBC-
filled microholes (we assumed that there is no flow through a microhole when a WBC is 
trapped) and obtained the resulting maximum pressure difference across the remaining 
open microholes in the cluster. A 3 psi pressure difference between the inlet and outlet of 
the simulated fluidic domain was used. Our results (Figure 3.4) suggest that the 
maximum pressure difference (ΔPmax) across the open (unfilled) microholes in a cluster 
remains relatively stable for up to ~70% microhole occupancy (occupancy = number of 
WBC-filled microholes in the cluster / total number of microholes in the cluster). 
However beyond 70% microhole occupancy, ΔPmax rises considerably which can lead to 
cell escape and reduced trapping efficiency. Considering the 70% occupancy limit and 
the fact that our microfluidic chip has a total of 10,700 microholes, it is expected that the 
chip can efficiently trap up to ~7,500 WBCs (70% occupancy) before there is a 
significant pressure drop across the remaining open microholes. That number of WBCs is 
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compatible with finger-prick point-of-care devices that typically process ~0.5 μl of whole 
blood [67] (0.5 μl of blood contains an average of 3,000-5,000 WBCs in healthy 
individuals).  
 
Figure 3.4: (A) COMSOL geometrical model used to simulate the pressure profile 
through an individual microhole cluster. The arrows signify the direction of flow into the 
device, passing through the microhole cluster and the bottom microfluidic layer and 
subsequently exiting through the outlet channel. The cross section schematic shows the 
pressure difference across an unoccupied microhole. (B) Pressure profile (in Pa) has been 
presented for the top plane of the bottom microfluidic layer (indicated in green). The 
white and the dark circles indicate the occupied and the unoccupied microholes 
respectively. (I), (II), (III) and (IV) correspond to 0, 18, 31 and 34 microholes occupied in 
the cluster (out of 37 holes). (C) Maximum pressure difference across a microhole cluster 




Furthermore, using the duel modeling approach described above and assuming 
pressure driven flow, we obtained the flow rate through each of the 17 clusters in a single 
inlet fluidic arm (Figure 3.5). We observed that the maximum and minimum relative 
flow rates (the relative flow rate is the ratio of the flow rate through a cluster divided by 
the total flow rate entering the inlet fluidic arm) were 6.3% and 5.7% respectively, 
indicating that the flow is divided almost equally among all clusters in a single inlet 
fluidic arm. This small variation can be attributed to the high microfluidic resistance of 




) which exceeds the resistance 









three and two orders of magnitude respectively. Maintaining a uniform flow distribution 
among all clusters in an inlet fluidic arm ensures an equal probability of trapping WBCs 
in the array. We avoid modeling the entire biochip, as all fluidic arms are connected in 







Figure 3.5: (A) Resistive electrical circuit to analyze the distribution of flow through 
different trapping microhole clusters (1-17) along the length of one of the 17 microfluidic 
inlet arms. Rcluster 1-17 indicate the fluidic resistances of the microhole clusters 1-17 
respectively. All the resistances used for the resistive electrical circuit modeling have 
been illustrated using a 3D cross section. Rconnector exceeds any other resistance in the 
network by at least two orders of magnitude. This resistive circuit was analyzed using LT 
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Spice IV software to obtain the flow rates through each of the 17 microfluidic arms. (B) 
% of the total flow passing through each of the microhole clusters in the beginning of the 
flow (no cell trapped). Flow distributes almost equally among all the 17 clusters.   
________________________________________________________________________ 
 
3.3.2 Maximum WBC trapping efficiency  
In order to obtain the optimum pressure that resulted in the highest trapping 
efficiency (ETrap), we conducted experiments at a pressure range of 1-7 psi with blood 1 
μl blood samples containing at least 200-500 WBCs (Figure 3.6). We defined ETrap at a 
given pressure as the percentage ratio of WBCs captured in the cell trapping array over 
the total number of WBCs processed through the biochip: 
 
 
The total number of WBCs was calculated by adding the number of WBCs that 
remained in the inlet region (Nin), the ones that trapped in the array (Narray) and the ones 
that escaped in the outlet region of the biochip (Nout). We also calculated the WBC 
escape yield (Yescape) that is the percentage ratio of Nout over the sum of Narray and Nout. 
The Yescape does not consider the Nin and hence it is a more realistic indicator of the 
ability of the microhole array to capture WBCs. 
 
Our results indicate that the ETrap reaches a maximum value of ~90% (average 
from 4 measurements) at 3 psi. At lower pressures, ETrap decreases by approximately 
10%. This decrease can be attributed to the higher number of WBCs remaining in the 
inlet region due to the low flow rate/WBC speed. Beyond 3 psi, ETrap decreases linearly 
with pressure as a larger number of WBCs squeeze through the microholes and escape 
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the biochip. It was also observed that a slightly higher percentage of WBCs escape the 
array at 1-2 psi when compared to the optimum pressure of 3 psi (Figure 3.6, % WBC 
escape curve). This counterintuitive observation can be attributed to the longer time that 
is required for the 1 μl of blood sample to flow through the biochip at low pressures. A 
prolonged processing time causes initially trapped WBCs to squeeze out of the array and 
finally exit the biochip. Beyond 3 psi, as anticipated, the Yescape increases with pressure 
reaching a value of 24-30% at 7 psi. For pressures 7 psi and above, the high flow rate 
resulted in an inaccurate count of the number of WBCs exiting the biochip using the 
imaging modality described earlier. At pressures 1 psi and below, the flow was extremely 
slow, leading to an aggregation of a high number of WBCs in the inlet region. 
 
Figure 3.6: Biochip trapping efficiency and WBC escape % versus pressure. Each data 
point represents result from a single WBC trapping experiment using a new biochip for 
every experiment. Four devices were used for each pressure value. For all these 
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experiments, the number of input cells was in the range 180-500. Maximum trapping 
efficiency was obtained for 3 psi pressure. Snapshot depicts the fluorescently tagged 
white blood cells trapped in the microholes. 
________________________________________________________________________ 
 
3.3.3 WBC trapping efficiency versus number of processed WBCs  
We furthermore measured the trapping efficiency for different WBC 
concentrations (100–1000 WBCs/μl) at the optimum pressure of 3 psi (Figure 3.7A). We 
chose ~100 WBCs per μl to be the lower limit as this represents the extremely low 
number of WBCs present in patients with a weak immune system (e.g. end-stage AIDS 
patients). To achieve low WBC concentration values, blood samples were diluted by 5-6 
fold after the lysis step. In the above range of input WBC concentrations, ETrap exhibited 
small variations, ranging between 87-95%. The WBC escape percentage (Figure 3.7B) 
varied between 1.8 - 3.6%, indicating that a very low number of processed WBCs was 
able to squeeze out of the array.      







Figure 3.7: (A) Biochip trapping efficiency versus number of input WBCs. (B) WBC 
escape % versus number of WBCs entering the cell trapping region (i.e. total number of 
input WBCs – number of WBCs stuck in the inlet region). Each data point represents 
result from a single WBC trapping experiment using a new biochip for every experiment. 
For all these experiments, 3 psi pressure was used. The trapping efficiency has an 8% 







We presented a novel 3D microfluidic architecture for capturing WBCs. Although 
the trapping efficiency of our biochip is higher than other size-based cell trapping 
approach by 5-15% [27], the ultimate limit of trapping all WBCs was not achieved for 
two reasons: (i) a small number of WBCs – probably the ones with the smallest diameter 
(e.g. lymphocytes) - were able to escape the array and (ii) some WBCs adhered at the 
inlet of the biochip. The latter reason had a dominant effect on reducing the trapping 
efficiency as the number of WBCs adhered at the inlet region was 2-3 times higher than 
the number of WBCs that escaped the microhole array. We anticipate that the 
functionalization of the microfluidic walls with a blocker against non-specific protein 
binding (e.g. bovine serum albumin (BSA) solution) [68] would minimize cell adherence 
and therefore significantly increase the trapping efficiency. Moreover, reducing the 
diameter of the microholes could further increase the trapping efficiency as the smallest 
WBCs will not be able to escape. An alternative strategy for capturing the smallest 
WBCs would be to decrease the thickness of the bottom microfluidic network. Such an 
approach is not recommended though as it can dramatically increase the fluidic resistance 
and therefore the time needed to process the blood sample. 
 
Our simulation results indicate that the ETrap of the proposed design is not affected 
by the total number of WBCs trapped as long as that number does not exceed ~7,500 
WBCs (70% occupancy of the array). That number is larger than the number of WBCs 
expected in most patients with compromised immune system (3,500-5000 WBCs/ μl). In 
52 
 
any case, the size of the microhole array can be easily scaled up if a large number of 
WBC needs to be processed.  
 
Finally, we should emphasize that all our experiments were performed with lysed 
human whole blood samples. The removal of RBCs from whole blood was necessitated 
due to their overwhelming number (~6 million RBCs in 1 μl) over the number of WBCs. 
Experiments were also performed with whole blood samples, but they were not 
successful: RBCs tend to stick to the microhole array, clogging the biochip. The clogging 
was not that severe when highly diluted whole blood samples (1:100 blood/buffer) were 
used; however the time required for processing the large volume of the diluted sample 
increased considerably (15-20 min at 3 psi). This resulted in a decrease in the trapping 
efficiency as many trapped WBCs eventually squeezed out of the microhole array. Future 
biochip designs can incorporate an on-chip RBC lysis chamber [69] and/or a metering 
chamber [70, 71] upstream of the microhole array. Such an integration scheme would 
eliminate the various off-chip lysis/dilution steps and potentially improve WBC viability 
as well as the overall performance of the biochip. 
 
3.5 Conclusions  
Monitoring of diseases that compromise the immune system (e.g. HIV/AIDS, 
aplastic anemia) is performed by counting WBCs and/or their subtypes. In this chapter, 
we presented a novel microfluidic chip for trapping and counting WBCs in minute 
volumes of lysed, diluted blood samples. The biochip incorporates an array of ~10,700 
microholes that is sandwiched between two microfluidic networks. This unique 
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architecture enables the three-dimensional confinement/trapping of WBCs in the array, 
resulting in a high trapping efficiency (>87%). Although, the current design requires the 
use of a fluorescent microscope for counting the number of WBCs, we envision the 
development of an integrated optofluidic system that will report the WBC count 
automatically. The use of such a system can be extended to other types of cells including 
specific sub-populations of WBCs (e.g. CD4+T cells) or even circulating tumor cells 
(CTCs) for point-of-care monitoring at home, at the physician’s office or at a resource-




A Polymer-based, Planar Microlens Array For Imaging Micron-sized Objects 
 
In this chapter, we present a novel microfabrication approach for obtaining arrays 
of planar, polymer-based microlenses. The proposed microlenses arrays consist of 
deformable, elastomeric membranes that are supported by polymer-filled microchambers. 
Each membrane/microchamber assembly is converted into a solid microlens when the 
supporting UV–curable polymer is pressurized and cured. By modifying the microlens 
diameter (40-60 µm) and curing pressure (7.5-30 psi), we demonstrated that it is possible 
to fabricate microlenses with a wide range of effective focal lengths (100–400 µm) and 
numerical apertures (0.05-0.3). We obtained a maximum numerical aperture of 0.3 and 
transverse resolution of 2.8 µm for 60 µm diameter microlenses cured at 30 psi. These 
values were found to be in agreement with values obtained from opto-mechanical 
simulations. We envision the integration of these microlenses arrays with cell capturing 
microfluidic biochips (presented in chapter 3) for point-of-care cell counting applications. 
 
4.1 Introduction 
Microlenses are used in optical communication [72, 73], displays [74, 75], optical 
sensors [76, 77], photolithographic systems [78, 79]  as well as in biomedical imaging 
applications [80-82]. Recent advances in micromachining technology led to the 
development of a variety of microlens microfabrication approaches including photoresist-
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reflow and transfer methods [35, 83], ink jet processes of UV curable polymers [37], hot 
embossing techniques [84], micromolding using silicon substrates [44, 85], soft 
lithography-based replication processes by molding various materials against rigid or 
elastomeric molds [41, 42, 86]. Photoresist-reflow methods rely on the surface tension of 
the photoresist to form a smooth microlens surface. These methods require accurate 
control of the microfabrication parameters (photoresist thickness, hydrophobicity) and 
produce microlenses with small numerical aperture (NA) due to the small aspect ratio 
(thickness vs diameter) of the patterned photoresist. Ink-jet methods are serial processes 
that require an elaborate experimental setup for accurately dispensing small drops of the 
optical material onto a rigid substrate. The properties of ink-jet processed microlenses 
depend on the rheological properties of the dispensing material (viscosity, surface 
tension), making the fabrication of microlenses with small diameters (<100 µm) and large 
aspect ratio (to achieve high NA), a challenging task. Hot embossing techniques produce 
microlenses with rough surfaces and suffer from post-embossing shrinkage. Fabrication 
of silicon molds requires isotropic wet etching of silicon and deposition of silicon 
oxide/nitride as the etchant mask. These fabrication steps are extremely time consuming 
and expensive. Soft lithography-based replication processes provide low-cost microlens 
arrays whose properties depend on the quality of the master mold.  These processes take 
advantage of the excellent optical [87] and mechanical [88, 89]  properties of the 
polydimethylsiloxane (PDMS) elastomer. PDMS has low elastic modulus, minimum light 
absorption in the visible spectrum and extremely low autofluorescence, it is therefore an 




In this work, we describe a novel array of polymer-based, solid microlenses with 
a numerical aperture (NA) of ~0.3. Key element is the microfabrication of an ‘inflatable’, 
polymer-filled PDMS mold that consists of an array of circular microchambers enclosed 
by flexible membranes. When the mold is inflated, the microchamber/membrane array is 
converted into a microlens array. Using a UV-curable polymer as a filling medium, the 
microlens arrays can be subsequently solidified when the desired focal length is obtained. 
The proposed approach has three major advantages: a) the microlens focal length can be 
adjusted by regulating the pressure applied to the filling polymer during curing, b) the use 
of PDMS as the mold material enables large membrane deflections that result in 
microlenses with high NA, and c) the optical properties (e.g. index of refraction) of the 
microlenses can be varied as there is a large collection of commercially available curable 
materials. We envision such microlens arrays to play a key role in various lab-on-chip 
detection systems for imaging micron-size objects (cells, viruses, etc.) [33, 92]. In 
particular, they can be integrated with the WBC capturing biochip (discussed in chapter 
3) for the development of a point-of-care WBC counting system. 
 
4.2 Design and Microfabrication of the Microlens Array 
The inflatable PDMS mold has a two-layer architecture (Figure 4.1): (i) the first 
layer (the ‘microlens’ layer) contains the circular microchamber/membrane array, and (ii) 
the second layer (the ‘support’ layer) contains an array of thick (~200 μm thick) square 
microwells aligned on top of the microchamber/membrane array. The main purpose of 
the second layer is to facilitate the handling of the thin first layer during the 
microfabrication process (see next paragraph for details). A microfluidic network 
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patterned on the first layer is used to deliver the UV-curable polymer into the 
microchambers. The increase in pressure within the microfluidic network induces a 
uniform deflection of the PDMS membranes across the array. That results in the 
formation of an array of plano-convex microlenses with a pressure-dependent focal 
length and NA. When the pressure is stabilized within the network (typically in few 

















Figure 4.1: (A) A picture of a 9x11 PDMS-based, planar microlens array. The right inlet 
is used to fill up the microfluidic network with the UV curable polymer (the left inlet is 
not used in the depicted design). Scale bar, 1.5 mm. (B) A close-up view of 16 cured 
microlenses of different diameters.  Each microlens sits beneath a square microwell. 
Scale bar, 200 µm. A magnified top view of a 60 µm in diameter microlens cured at 30 
psi and a schematic diagram of its cross section are shown on the right (I and II 





The microfabrication process of the microlens array involves (Figure 4.2): i) the 
fabrication of two SU-8 master molds (for each of the two PDMS layers) using standard 
photolithographic processes, ii) the fabrication of the inflatable PDMS mold from the two 
SU-8 master molds using soft-lithography, and iii) the injection and curing of the UV-
curable polymer into the inflatable PDMS mold. 
  
The fabrication of the first SU-8 master mold (corresponding to the microlens 
PDMS layer) is performed in a two-step photolithographic process [90]. A 13 µm thick 
film of SU-8 photoresist is patterned on a silicon wafer to define the microfluidic 
network, followed by the patterning of a second, 40 µm thick, SU-8 film to form the 
circular microchambers. A 20:1 PDMS mixture is then spun at 1750 rpm and cured on 
the two-step SU-8 mold to obtain a ~52 µm thick PDMS layer. Such a PDMS 
composition results in a layer of low elastic modulus (<1MPa [93]), which is necessary to 
achieve large membrane deflections, and therefore high NA microlenses. By accurately 
measuring the thickness of SU-8 circular microchambers and the PDMS microlens layer, 
we estimated the PDMS membrane thickness to be 12.1 ± 1.4 µm (16 measurements 
were taken from different runs using a profilometer). 
 
The second SU-8 mold (corresponding to the support PDMS layer) is fabricated 
by patterning a 50 µm thick SU-8 film. The design incorporates an array of 200 µm x 200 
µm square microwells, each one sitting on top of a single microlens. A thick (~1 mm) 
PDMS layer (the support layer) is subsequently cured, peeled off and air-plasma bonded 
(90 W, 35 sec) to the PDMS microlens layer. Finally, the two-layer PDMS assembly is 
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detached from the first SU-8 mold and bonded to a 175 µm thick glass slide to create the 
sealed inflatable PDMS mold. The use of the support PDMS layer is critical for peeling 
off the thin microlens layer as it provides structural integrity and eliminates the microlens 
membranes from tearing apart. The inflatable PDMS mold is then filled with a UV 









4.3 Results  
To obtain the optical properties of the proposed high NA, solid microlenses, we 
characterized an array of 40 µm and 60 µm diameter microlenses following the 
microfabrication process described above. A high index of refraction UV-curable 
polymer (Norland 60, index of refraction n = 1.56) was injected into the inflatable PDMS 
mold and cured (10 min, at 365 nm (Entela UV lamp)) under constant pressure to ensure 
uniform deflection across the membrane array. The effective focal length (EFL) of the 
cured microlens device was measured for a range of curing pressures (7.5-30 psi) using a 
custom-made optical setup (Figure 4.3). The EFL corresponds to the distance between 
the top surface of a microlens and the best-focused image formed when passing a laser 
beam (532 nm) through the microlens. We followed a 2-step sequence to determine the 
EFL: i) the top surface of a microlens was visually identified and set as the reference 
plane (plane I), and ii) the plane containing the image of the focused laser beam was 
brought into the imaging plane of the microscope objective (plane II) by vertically 
moving the microlens. The distance between these two planes corresponded to the EFL of 
the microlens. Plane II was identified by extracting the plane of the maximum light 








Figure 4.3: Schematic of the experimental setup for characterizing the optical propereties 
(effective focal length (EFL), point spread function (PSF)) of the microlens device. A 









The EFL of both the 40 µm and 60 µm diameter microlenses exhibited a strong 
dependence on the curing pressure (Figure 4.4). EFL changes up to ~200 % were 
measured over the entire pressure range. For low pressures (< 7.5 psi), the circular 
membranes undergo small (sub-µm) deflection. These microlenses weakly focus the laser 
beam resulting in a large depth of focus (several mm’s) that makes it difficult to assign a 
single value to the focal length. High pressures (>30 psi) resulted in breakage of the 
microlens membranes. Experimental EFL data were also compared with opto-mechanical 
simulation values. The pressure-dependent microlens profiles were simulated using 
commercially available finite element analysis software (ANSYS). The deflected 
membrane profiles were imported into an optical design software (OSLO LT) to 
determine the corresponding EFLs. Simulations were performed for a membrane 
thickness of 10.7 µm and 13.5 µm to capture the upper and lower limit of the 
corresponding measured values. The elastic modulus and Poisson ratio of the PDMS 
membrane was set to 3 MPa [89] and 0.49 respectively. A refractive index of 1.41, 1.56 
and 1.51 was used for the PDMS, the UV-curable polymer and the glass slide 
respectively. The experimental EFL values for both the 40 µm and 60 µm diameter 






Figure 4.4: Effective Focal Length (EFL) versus curing pressure for (A) 40 µm and (B) 
60 µm diameter microlenses. Experimental and opto-mechanically simulated EFL values 
are obtained for a pressure range of 7.5-30 psi. Each data point is the average of 16 
measurements from 2 microlens devices (8 microlenses/device). The measured EFL 






The numerical aperture (NA) of the microlenses (for use in air) was estimated 
from [94] where a and F represent the microlens radius and EFL respectively.  














a1tansinNA                                         (1) 
Based on the EFL values reported above, a maximum NA of ~0.17 and ~0.3 was 
obtained for 40 µm and 60 µm diameter microlenses cured at 30 psi respectively (Figure 
4.5). The light loss through a single microlens was obtained by measuring the decrease in 
the light intensity of white light passing through the microlens device. For microlenses 










Figure 4.5: Numerical Aperture (NA) versus curing pressure for (A) 40 µm and (B) 60 
µm diameter microlenses. NA values are calculated using the EFL values presented in 
Figure 4.4. 60 µm diameter microlenses (with lower EFL) have higher NA than 40 µm 




To characterize the surface profile of a single microlens from the array (Figure 
4.6A) we used a white-light interferometer (Veeco NT9100). We obtain direct optical 
access to the array by immersing the microlens device in acetone for 10 minutes and 
manually detaching the support layer. A 25 nm thick, gold layer was subsequently 
evaporated on the microlens surface to acquire a clean interferometric image. The PDMS 
membrane profile of a 60 µm diameter solid microlens showed a maximum deflection of 
~6 µm when cured at 30 psi, corresponding to a microlens with an aspect ratio of 10:1 
(Figure 4.6B). The microlens profile (Figure 4.6) allows us to determine the minimum 
microlens pitch (microlens center-to-center distance). For 60 µm microlenses cured at 30 
psi, the membrane deformation extends up to ~40 µm from the center of the microlens, 
and therefore they can be placed as close as 80 µm apart. Microlenses of smaller diameter 





Figure 4.6: (A) Surface profile of a 60 µm diameter microlens (cured at 30 psi) obtained 
using a white light interferometer. (B) A 2D microlens profile measured along its midline 





The depth of focus and the transverse resolution of such a microlens (60 µm 
diameter solid microlens, cured at 30 psi) were calculated by measuring its axial intensity 
profile and point spread function (PSF) respectively (Figure 4.7). To obtain the axial 
intensity profile, we extracted the maximum intensity from imaging planes above and 
below the best focused plane in an optical setup similar to the one used for obtaining the 
EFL. The theoretical value of the depth of focus (DOF) was estimated to be ~6 µm [95]. 
Within that distance, the maximum intensity dropped by 5%. To obtain the PSF of the 
microlens, we measured the background-corrected in-plane intensity distribution (I[x,y]- 
I0) at the best-focused plane and normalized that value by the background intensity (I0). 
The transverse resolution of the microlens, defined as the full width at half maximum 
















Figure 4.7: (A) Relative intensity (maximum intensity for a given axial plane normalized 
with the maximum intensity measured at the best focused plane) along the optical axis of 
a 60 µm diameter microlens as a function of the distance from the best-focused plane. 
The pictures depict the focused laser beam as imaged at the focal plane and at two out-of 
focus planes. Scale bar, 10 µm. (B) The PSF of the same microlens represented as the in-
plane intensity distribution (I[x,y] – I0) at the best-focused plane, normalized with respect 





Finally, we demonstrated that it is possible to use the fabricated microlenses to 
magnify and image micron-size resolution features patterned on a chrome mask (Figure 
4.8). 3 µm wide line features were clearly visible after placing the microlens device 
between the chrome mask and a 1x microscope objective (we used Olympus SZX16 
stereo microscope). Minimum distortion was observed at the center region of the 
microlens. 
 
Figure 4.8: Micron-size resolution patterns imaged: (A) without using a microlens, and 
(B) through a 60 µm diameter microlens (NA ~ 0.3). Equally-spaced, 3 µm wide lines are 





4.4      Conclusions 
In this chapter, we demonstrate a novel microfabrication process for obtaining 
polymer-based, planar microlens arrays. The microlens array comprises of polymer-filled 
circular microchambers enclosed by deformable, elastomeric membranes. Each 
microchamber is transformed into a solid microlens when the UV-curable polymer is 
pressurized and cured. By varying the curing pressure (7.5-30 psi), microlenses with a 
wide range of EFL (100-400 µm) and NA (0.05-0.3) have been fabricated from 40 µm 
and 60 µm diameter membranes. We have obtained a NA of 0.3 and transverse resolution 
of 2.8 µm for 60 µm diameter microlenses (cured at 30 psi). Smaller diameter (40 µm) 
microlenses have lower NA than larger diameter (60 µm) microlenses for similar curing 
conditions. The proposed microlens design is compatible with a wide variety of curable 
polymers and therefore it can be used to obtain microlenses with different optical 
properties. We envision the use of these planar microlenses in lab-on-chip detection 
systems for imaging micron-sized biological specimens. These microlenses can be 
integrated with the cell trapping biochips (such as the one in chapter 3) for obtaining 





A High Numerical Aperture Doublet Microlens Array 
 
This chapter presents a high numerical aperture, doublet microlens array for 
imaging micron-sized objects. The proposed doublet architecture consists of glass 
microspheres trapped on a predefined array of silicon microholes and covered with a thin 
polymer layer. A standard silicon microfabrication process and a novel fluidic assembly 
technique were combined to obtain an array of 56 μm in diameter microlenses with a 
numerical aperture (NA) of ~0.5. This NA value was a significant improvement over the 
0.3 NA polymer-based microlenses presented in chapter 4 and hence these microlenses 
are better suited for high resolution imaging of cells and tissues. Using the doublet 
microlens array, we demonstrated brightfield and fluorescent image formation of 
microobjects directly on a CCD sensor without the use of intermediate lenses. The 
proposed microlens fabrication technology is a significant advancement towards the 
unmet need of inexpensive, miniaturized optical modules, which can be further integrated 
with lab-on-chip microfluidic devices and photonic chips for a variety of high-end 
imaging/detection applications. In particular, these microlenses arrays can be integrated 
with the WBC capture biochip presented in chapter 3 for fluorescence based imaging and 






Modern optical imaging-based research and industrial systems rely on the use of 
bulky and expensive objectives lenses. Despite their superior performance in resolving 
submicron features under low-light conditions, these lenses can detect only one sample at 
a time (that lies within their field of view (FOV)), while manufacturing limitations do not 
allow miniaturization and integration with emerging micromachined devices, including 
miniature CCD sensors [97], photonic chips [98] and microfluidic biochips [99]. The 
development of on-chip lens-based optical modules entails the miniaturization of these 
lenses while maintaining superb imaging quality. Such miniaturized, typically 
microfabricated lenses (also known as ‘microlenses’) can be used in displays [75, 100, 
101], for optical coupling [102-104] and surface microstructuring [105] as well as in 
various biomedical imaging applications [106-108].  
 
A number of microlens microfabrication approaches have been proposed over the 
past three decades. Photoresist reflow and transfer methods are the earliest methods for 
fabricating microlenses [35, 83, 109]. These microlenses have a low light collecting 
capability (indicated by a low numerical aperture (NA)) and are unable to form a resolved 
image of weakly light-emitting micron-sized objects. A modified approach called the 
‘boundary confined method’ has been proposed to obtain high NA (NA~0.54) 
microlenses [110]. Similar to other photoresist reflow approaches, this method requires 
accurate control of the surface tension of the photoresist-substrate interface. Ink-jet 
printing of UV-curable polymers has been another approach for fabricating microlens 
arrays [37, 38]. This method requires an expensive setup for accurately dispensing a 
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polymer on a rigid substrate. Recently, fabrication of high NA (NA~0.37) microlens 
arrays using ink-jet printing of UV-curable polymers on hydrophobic glass substrates has 
been reported [111]. These processes require an elaborate control of the material 
properties (viscosity, surface tension) of the polymer as well as of the hydrophobicity of 
the substrate surface. Microfabrication of high NA microlenses has also been proposed 
using focused ion beam milling and femtosecond laser direct writing technologies [39, 
40]. These microfabrication processes are serial processes and require expensive 
equipments and experienced personnel. Soft lithography-based approaches in which 
optical materials are molded against rigid and elastomeric molds to obtain microlenses 
have also been demonstrated [41, 42]. These methods are simple to implement but the 
microlens quality is strongly dependent on the surface finish of the mold. Alternatively, 
planar, polymer-based arrays of microlenses can be microfabricated by UV-assisted 
curing of microfluidic networks [112]. These planar microlenses have a relatively high 
NA (NA~0.3) when compared to other planar microlenses but are not amenable to an 
easy integration with other optical and microfluidic devices.  
 
High NA (NA~0.64) spherical microlenses have also been microfabricated by 
injecting SU-8 photoresist through microfabricated nozzles and utilizing surface tension 
to form micro-balls [113]. These microlenses largely vary in size due to fluctuations in 
the injection pressure and the contact angle between the photoresist and the substrate. 
Another process for spherical microlens fabrication involves polymer molding against 
isotropically etched silicon master molds [44]. The surface quality of the mold is highly 
dependent upon the precise balance of reagents used to etch the master mold. Finally, a 
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number of high NA, spherical microlens fabrication approaches employing the use of 
glass or polystyrene microspheres have been proposed [114, 115]. However, none of 
these microlenses have been shown to form the image on their own on an imaging sensor 
without the aid of additional optical elements. Several microlenses have been proposed 
for amplifying the light signal on the imaging sensor, hence increasing the effective 
numerical aperture of the imaging system [116-121]. However, all these approaches 
involve the use of macroscopic lenses in addition to the microlens arrays for image 
formation on the imaging sensor.   
 
We propose a novel microfabrication approach for obtaining low-cost, high-NA 
arrays of doublet microlenses for imaging micron-sized objects without the need of any 
additional lenses. These microlenses are made out of glass microspheres with a 
transparent polymer spun on them. Planarizing one side of the microlenses with a 
transparent polymer layer enables an easy integration of the microlens array with 
microfluidic lab-on-chip devices and other photonic chips. The microlenses array is 
microfabricated using a combination of silicon micromachining, soft lithography and 
fluidic assembly. To our knowledge, this is the first demonstration of magnified image 
formation on a CCD sensor using a microlens array without use of intermediate lenses. 
An array of these doublet microlenses has the following advantages: i) equivalent optical 
performance (resolution, NA) to a conventional microscope objective, ii) simultaneous 
imaging of a large number of objects, iii) easy integration with other micromachined 
modules, including microfluidic and optical chips, iv) direct image formation on an 
imaging sensor without any extra lenses and v) low microfabrication cost. This microlens 
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fabrication approach not only provides higher NA (0.5) microlenses as compared to the 
0.3 NA planar polymer-based microlenses presented in chapter 4 but also enables direct 
image formation on an imaging sensor (not possible with the planar microlenses owing to 
a thick PDMS support layer). With these advantages, we believe that the doublet 
microlens arrays can be readily integrated with the WBC capture biochip presented in 
chapter 3 to develop a point-of-care WBC counting biochip.   
 
5.2 Design and Microfabrication of the Doublet Microlens Array 
The proposed doublet microlens array consists of glass microspheres, fluidically 
assembled on top of an array of wafer-through microholes (Figure 5.1). The microhole 
array captures/places the microspheres in a predefined pattern, while it creates a clear 
optical path for the collected light to reach the imaging sensor. The microlens array 
collects light originating from micron-sized objects and forms an image of these objects 
on the imaging sensor. It is intended to function as a magnifying lens: objects placed at a 
plane slightly below the focal plane of the microlens array, appear magnified at the 
imaging sensor. To ensure that the magnified image is in focus on the plane of the sensor 







Figure 5.1: (A) A 10x10 array of 56 µm in diameter doublet microlenses. Scale bar, 500 
µm. (B) A schematic of the cross section of the microlenses array. The microlens 
diameter is defined by the diameter of the microhole. (C) A collimated light beam is 
focused at a point (focal point) right below the top surface of the PDMS layer. The 
distance between the focal point and the silicon dioxide surface is the microlens effective 
focal length (EFL). a is the microhole (microlens) diameter and r is the microsphere 
diameter. (D) Mechanism of image formation using the doublet microlens array. The 
object is placed on the surface of the microlens. A magnified image is formed directly on 
a CCD sensor. 
________________________________________________________________________ 
 
The microfabrication of the doublet microlens array involves three steps (Figure 
5.2): i) microfabrication of the microhole array, ii) assembly of glass microspheres on the 
array, and iii) spinning of a polymer layer on the captured microspheres to form the 
doublet microlenses. Specifically, a 2 µm thick PECVD silicon dioxide is initially 
deposited on a ~500 µm thick silicon substrate. An array of 56 µm diameter microholes is 
then patterned and etched on the oxide layer using standard photolithography and reactive 
ion etching (RIE). Deep reactive ion etching (DRIE) is further employed to fabricate 
wafer-through circular microholes in the silicon substrate. Subsequently, the silicon 
substrate is thinned down to 200 µm using a combination of lapping and chemical-
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mechanical polishing (CMP). An aqueous solution containing glass microspheres (60 µm 
nominal diameter, refractive index 1.51 at a wavelength of 589 nm; catalog no. 02718-
AB, Structure Probe, Inc.) is then dispensed on the oxide-coated silicon surface. A 
suction force is subsequently applied from the other side of the substrate to assemble and 
trap the glass microspheres atop of the microhole array. Doublet microlenses are finally 
obtained by spinning and curing (65ºC, 1 hour on a hot plate) a ~75 µm thick (spun at 






Figure 5.2: Microfabrication process of the doublet microlens array. Key concept is the 





5.3 Results and Discussion 
We performed optical simulations using OSLO software to ascertain the effective 
focal length (EFL) of the fabricated microlenses (for all simulations, we assumed a 
wavelength of 580 nm). We defined the microlens EFL as the distance between the best 
focused plane of a collimated light beam passing through a doublet microlens and the 
silicon dioxide-coated wafer surface (Figure 5.1C). A refractive index of 1.41 and 1.51 
was used for the PDMS and the glass microspheres respectively. EFL values of 65-75 µm 
were obtained for glass microspheres ranging 57-63 µm in diameter. Experimental EFL 
values were obtained for individual microlenses in the array using a collimated white 
light (see [112] for details on the experimental setup used to measure the EFL). The EFL 
measurement process involved obtaining the best focused plane by capturing a stack of 
images along the microlens axis and finding the plane with the maximum light intensity. 
A 40X (0.6NA) microscope objective was used to image the best focused plane. EFL 
values measured for 20 microlenses in the microlens array varied from 63 to 71 μm. 
These values correlated strongly with the EFL range obtained from optical simulations. 
Such a variation on the measured EFL between microlenses can be attributed to 
variations of the microsphere diameter (5%, given by the manufacturer). We also 
performed optical simulations to assess the dependence of the EFL on the PDMS curing 
conditions (temperature, time) as those are known to affect the PDMS refractive index 
[122]. For two extreme curing cases (48 hours at 25ºC and 1 hour at 150ºC), the EFL was 
found to change by less than 1 μm (assuming a change in the PDMS refractive index 
from 1.416 to 1.472 [122]). These results show that the EFL of our microlenses is not 
significantly affected by the PDMS curing conditions.    
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Furthermore, we used optical simulations to estimate the NA of the doublet 
microlenses as a function of microhole diameter (a) to microsphere diameter (r) ratio 
(figure 3). For our fabricated microlenses (a = 56 μm, r = 60 μm, a/r = 0.93), a NA of 
0.495 was obtained. This NA value is very close to the maximum theoretical NA value 
(0.53, a/r = 1.0) achievable using this microfabrication method. It should be emphasized 
that objectives with a NA of 0.35-0.4 are commonly used in microscopy for imaging cells 




Figure 5.3: Simulation results depicting the dependence of the numerical aperture (NA) 
on the microhole to microsphere diameter ratio (a/r). A NA value of 0.495 was estimated 





To measure the depth of focus (DOF) of the doublet microlenses, we obtained the 
axial light intensity profile of a collimated light beam that was focused through the 
microlens array (Figure 5.4). The collimated light beam was generated by placing a point 
source of light (a halogen lamp) 25-30 cm away from the microlens array. The average 
light intensity was obtained for imaging planes above and below the best focused plane 
(the focal plane) and normalized with respect to the average light intensity at the best 
focused plane (that corresponded to the maximum average intensity). Intensity values for 
all imaging planes were background-corrected. The DOF of the fabricated doublet 
microlenses (a/r = 0.93, NA~0.495) was estimated to be ~3.6 μm [95]. Within this 







Figure 5.4: Normalized intensity (with respect to the background corrected average 
intensity at the best focused plane) of a doublet microlens as a function of the axial 
distance from the best focused plane. The images depict a focused light beam at different 
axial planes. Scale bar, 10µm.   
________________________________________________________________________ 
 
Low (4X) and high (40X) magnification measurements were taken from a 4x4 
microlens array and from a single microlens respectively to obtain the point spread 
function (PSF) (Figure 5.5). The 4x4 array had 16 spatially distinguishable intensity 
peaks (Figure 5.5A), observed at the center of each microlens. The average value of the 
normalized intensity from those 16 peaks was 82.3% (standard deviation 19.6%), ranging 
from 44% to 100% between individual microlenses. This non-uniformity in the peak 







Figure 5.5: (A) PSF of a 4x4 microlens array. Scale bar of the image: 100 µm. (B) PSF 
of an individual microlens. Scale bar of the image: 10 µm. (A) and (B) plots were 
obtained using a 4X (NA=0.15) and a 40X (NA=0.6) microscope objective respectively. 
In both (A) and (B), normalized intensity values at a particular xy point were obtained by 
normalizing the background-corrected light intensity at that point with the maximum 






As described above, a major advantage of the proposed microlens array is their 
capability to form an image directly on an imaging sensor without intermediate lenses. To 
demonstrate the image formation capability and magnification achieved using these 
microlenses, we used a microlens array to image resolution patterns etched on a chrome 
layer, deposited on a glass substrate (Figure 5.6). A 640x480 CCD sensor chip (5.6 μm 
pixel size), dismantled from a web camera (Logitech QuickCam 3000) and a custom 
experimental setup utilizing x-, y- and z-axis manipulators, were used to acquire images 
and to align the patterns-microlens assembly with the imaging sensor chip (Figure 5.6A). 
A white light source was used to illuminate the resolution patterns. In this brightfield, 
transmission imaging mode, the microlens array was able to resolve various 1 µm and 2 
µm resolution patterns (Figure 5.6B(I)-(III)). The theoretical resolution was calculated 
to be 0.45 – 0.71 μm (for a 450-700 nm wavelength) [95].  
 
We also demonstrated the use of these microlenses for fluorescent imaging of 
micron-size objects. We obtained a magnified, fluorescent image of 4 μm in diameter 
polystyrene bead (excitation peak 505 nm, emission peak 515 nm, catalog no. F-8859, 
Invitrogen, Inc.) using a slightly modified setup for fluorescence imaging (Figure 
5.6B(IV)). The fluorescent beads were illuminated with a blue light obtained after 
passing white light (originated by a halogen lamp) through an optical band-pass filter 
(XF1073 475AF40; Omega Optical). A thin (~100 μm) long-pass emission filter (Yellow 
12 Kodak Wratten colour filter) was inserted between the microlens array and the CCD 
sensor to block the excitation light. The fluorescent image obtained for the bead was 
magnified by a factor of ~6. At this 6X magnification, a 56 μm diameter microlens (with 
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a 60 μm microsphere) is estimated to have a field of view (FOV) of ~9.3 μm (FOV = 
microhole diameter/magnification). The dimensions of the objects used for brightfield 
and fluorescence imaging correspond to an average cell diameter (e.g. blood cell) and 
hence the above imaging results validate the potential use of these microlenses for 













Figure 5.6: (A) Schematic of the setup for imaging micron-size resolution patterns using 
the doublet microlenses array. (B) (I) & (II) Brightfield, transmission images of 1 and 2 
μm line resolution patterns respectively using a 56 µm diameter microlens (NA~0.495). 
Equally spaced, 1 µm wide lines are clearly resolved by the doublet microlens. Scale bar, 
20 μm. (III) Brightfield, transmission image of a 5 µm square grid. Scale bar, 20 μm. (IV) 





5.4      Conclusions 
In this chapter, we have presented a novel doublet microlens array 
microfabrication approach for the direct visualization of micron-sized objects. Using 
these microlenses, we have demonstrated direct image formation on a CCD sensor 
without additional optical elements. These microlenses resolved 1 µm resolution patterns 
and had a numerical aperture of ~0.495. As a result, they can be considered as 
miniaturized microscope objectives and they provide a cheaper alternative for bulky and 
expensive microscope optics. They can readily find biomedical applications in imaging of 
cellular and subcellular components. Owing to their superior optical performance and 
ease of fabrication over the planar polymer-based microlens arrays, these microlenses 
provide a better option for integration with the WBC capture biochip. The integrated 




Conclusions and Future Work 
 
6.1 Conclusions 
White blood cells (WBCs) and their subtypes are indicators of the state of the 
human immune system. WBC count (total as well as differential) in human blood is, 
therefore, an important metric for diagnosis of a number of immunological diseases. Flow 
cytometry based instruments which have been used conventionally for WBC counting are 
bulky, resource intensive and not amenable for use at the point-of-care. Microfluidic lab-
on-chip technology with its unique features can be employed for developing miniaturized 
WBC counting systems. These features include: i) low sample and reagent requirements, 
ii) less power requirements, iii) precise and controlled delivery of sample and reagent 
volumes, iv) small size of the devices which are inexpensive and disposable, v) ease of 
operation and maintenance, vi) possible integration of the individual modules for cell 
capture, imaging and counting respectively, on a single platform and vii) fast and 
sensitive results owing to small sample volumes. Taking advantages of these features of 
the microfluidic lab-on-chip technology, we have envisioned a WBC counting system 
which will capture WBCs from human blood and simultaneously image and count them. 
In this thesis, we have developed individual modules which i) can capture WBCs and ii) 
can be used for imaging and counting WBCs. The important contributions of this thesis 
can be summed up as the following: 
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6.1.1  Microfluidic biochip with a 3D architecture for capturing WBCs  
Size based capture of WBCs is a commonly employed method of isolating WBCs 
from other blood components (RBCs and platelets). This method relies upon the bigger 
size of WBCs as compared to RBCs and platelets. A number of microfluidic approaches 
utilize membrane filters (with microholes) for capturing WBCs in a flow while allowing 
the RBCs and platelets to squeeze through [26, 27]. Although simple to fabricate and 
operate, these microfluidic devices have low (< 80%) WBC trapping efficiency. This can 
be attributed to the 2 dimensional confinement of WBCs in the filter holes (no constraint 
in the third dimension), hence allowing them to squeeze through and resulting into a 
lower trapping efficiency. To overcome this drawback of membrane filter based 
microdevices, we have developed a microfluidic biochip with a novel 3D cell trapping 
architecture for capturing WBCs.     
      
 The biochip incorporates a membrane with an array of photolithographically 
patterned microholes, sandwiched between two microfluidic networks. The WBCs 
flowing through the biochip are confined in the 3D space created by the microholes and 
the bottom microfluidic network resulting into a more efficient trapping. A high (>87%) 
WBC trapping efficiency was obtained using the biochip when WBCs suspended in a 
buffer solution were flown through the device at 3 psi injection pressure. The biochip 
design has been optimized to ensure equal cell trapping probability in all the regions of 
the biochip. The biochip has the flexibility of operation in both push (pressure) as well as 
pull (suction) mode. We envision that the biochip with its novel cell trapping design can 
not only be used for separating WBCs from other blood components but also for the size 
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based separation of other cells (e.g. circulating tumor cells) from biological samples 
(blood, urine, saliva etc.).  
 
6.1.2  High numerical aperture microlens arrays for imaging micro-objects 
Microscope objective lenses with a high light collection capability (high 
numerical aperture NA) are usually employed for high resolution imaging of biological 
micro-objects (cells, tissues etc.). However these objective lenses are bulky, expensive, 
have a small field-of-view and hence are not suitable for integration with microdevices 
manipulating cell and tissue samples. This limitation of conventional objective lenses 
necessitates the development of inexpensive microlenses that have an equivalent optical 
performance (NA, magnification) as the macroscale lenses and which can be easily 
integrated with the lab-on-chip microfluidic devices. To meet this requirement, we have 
developed two microfabrication techniques for obtaining high NA microlens arrays. 
 
         Planar, polymer-based microlens array using soft lithography 
This microlens array fabrication approach involves deflection of an elastomeric 
membrane integrated on the top of polymer-filled circular microchambers. Upon the 
application of pressure to the UV-curable polymer in the microchambers which is 
simultaneously cured by exposure to UV radiations, each membrane/microchamber 
assembly transforms into fixed focal length microlens. Large membrane deflection 
achievable by the use of an elastomeric material results into microlens with a highly 
curved surface profile. These microlenses have a high light collecting ability reflected in 
their high NA (~0.3) values. This microfabrication technique enables fabrication of 
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microlenses with a wide range of focal lengths and numerical apertures by varying the 
elastomeric membrane thickness, lens filling polymer and the applied pneumatic 
pressure.  
 
         Doublet microlens array using fluidic assembly of microspheres 
This microlens fabrication approach involves assembling glass microspheres on 
an array of silicon microholes using a novel fluidic assembly technique. The fabrication 
is complete by spinning a thin layer of transparent polymer on one side of the 
microspheres to planarize the microlens surface. A planar microlens surface enables an 
easy integration with other lab-on-chip microdevices. High NA (0.5) microlenses were 
obtained using this microfabrication technique. Using microspheres with varying 
refractive indices, doublet microlenses with a wide range of numerical apertures can be 
obtained. The doublet microlenses have been demonstrated to be capable of imaging 1 
μm resolution patterns directly on a CCD sensor without the any additional optical 
elements. Thus, they provide a cheaper alternative to more bulky and expensive 
microscope objective lenses and can be used for the development of new generation of 
miniaturized microscopes for biomedical applications.  
 
The two microlens arrays discussed in this thesis have an inexpensive fabrication 
process which can be scaled up to obtain 100s and 1000s of microlenses on a single 
substrate. With their high NAs (0.3-0.5), these microlens arrays can enable large field-of-
view high resolution imaging of micron-sized objects.  
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6.2 Future Work 
We envision that the work presented in this thesis can be extended in the 
following research directions: 
 
6.2.1 Cell trapping biochip with an integrated volume metering and RBC lysis 
chamber 
 The WBC capture performance of the biochip proposed in this thesis has been 
demonstrated using buffer suspended WBCs obtained after lysing RBCs from 1 μl of 
whole blood. In order to more accurately determine the WBC trapping efficiency of the 
biochip, we would essentially be required to count the WBCs in a given volume (e.g. 1 
μl) of whole blood before the blood enters the cell trapping region of the biochip. To 
achieve this functionality, we envision a cell trapping biochip with an integrated volume 
metering chamber (Figure 6.1). The metering chamber will not only ensure the injection 
of a fixed volume of blood in the cell trapping region but will also provide a window for 
imaging the blood cells before their entry in the cell trapping region. Hydrophobic valves 
which have been employed for flow control in microfluidic devices will also be 
incorporated in this device design [124-126]. These valves will help to control the flow of 
blood and buffer during the biochip operation. A hydrophobic pad patterned in the 
connecting narrow channel between the metering chamber and the cell trapping region 
will help to stop the flow of blood unless a higher pressure is applied to overcome the 
pressure barrier across the hydrophobic pad. A similar hydrophobic pad patterned at the 




Figure 6.1: Snapshot of the first prototype of a cell trapping biochip with an integrated 
volume metering chamber. The metering chamber of this prototype has a total volume of 
0.1 μl. Scale bar, 500 μm. 
________________________________________________________________________ 
The integrated biochip will work in the following manner: The fluorescently 
tagged whole blood is injected into the biochip through one of the inlets and the flow 
stops at the hydrophobic pad (at the metering chamber-cell trapping region interface). A 
fixed volume of blood fills up the metering chamber. WBCs are then imaged and counted 
in the metering chamber. This is followed by the injection of PBS solution through 
another inlet under pneumatic pressure. This pressure overcomes the pressure barrier 
across the hydrophobic pad and pushes the blood cells into the trapping region where 
WBCs are trapped and imaged. The WBC trapping efficiency (η) of the biochip will be 
given by:    
  
chamber  metering in the  WBCsof #
 WBCs trappedof #
η   
             
            Off-chip lysis of RBCs from whole blood involves a number of mixing and 







To avoid this WBC loss, some on-chip RBC lysis techniques have been proposed which 
completely eliminate centrifuging and vigorous mixing steps resulting into negligible 
WBC loss [69, 127]. We envision a modified form of the above biochip in which the 
metering chamber will be pre-functionalized with a detergent (e.g. Tween 20) during the 
fabrication process. This detergent will serve the purpose of lysing RBCs from the whole 
blood. A passive mixer will also be incorporated in the design of the metering chamber to 
ensure that the entire blood volume comes in contact with the detergent resulting into the 
destruction of most of the RBCs [128]. We believe that this integrated design will enable 
a more accurate measurement of the biochip WBC trapping efficiency. With the 
optimization of this biochip design, this can develop into a device for obtaining an 
accurate WBC count from human whole blood. 
 
6.2.2   Microfluidic-based oil immersion lens array 
  Oil-immersion objective lenses are employed for high resolution imaging 
applications. Immersion oil whose refractive index matches with that of the objective lens 
material increases the light collecting ability (and the NA) of the lens. With the aim to 
obtain high NA (~0.7-0.8) microlenses, we envision a variation of the doublet 
microlenses which incorporates high index of refraction oil-immersed ball lenses. High 
index of refraction microspheres will provide a higher NA than that obtained using the 
doublet microlenses (NA ~ 0.5) proposed in this thesis. 
 
The proposed microlens array will consist of sapphire ball lenses (refractive index 
1.77) integrated on the top of an array of immersion oil-filled microchambers (Figure 
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6.2). The oil/ball lens assembly will act as a high NA (~0.8) doublet lens and can be used 
for high resolution imaging of biological micro-objects.  
 
Figure 6.2: Cross sectional view of the proposed oil-immersion microlens array. A glass 
coverslip and a spacer will accurately define the distance between the lens and the sample 
object.  
________________________________________________________________________ 
We envision that the oil-immersion lens array can be used as an add-on module 
on low cost stereoscopes to enable high resolution, wide field of view imaging of 
biological samples in the lab, in the doctor’s office or in the field.    
 
6.2.3   Integrated biochip for on-chip capture, imaging and counting of WBCs 
 In this thesis, we have presented microfabricated modules which can be used for 
capturing WBCs (cell trapping biochip) and imaging and counting micro-objects 
(microlens arrays). We envision an integrated WBC counting biochip which will 
incorporate the optimized cell trapping module as well as the high NA microlens arrays. 
The integrated biochip will enable simultaneous capture and imaging/counting of WBCs 
from human whole blood. In addition to the biochip, the WBC counting system would 
comprise of a portable reader for counting the number of WBCs captured in the biochip 
(Figure 6.3). While the biochip will constitute the disposable part of the system, the 
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reader will form the permanent part and will be battery operated. The reader will be 
equipped with a laser diode for exciting WBC fluorescence, an achromatic doublet lens 
for collecting cell fluorescence from the microlenses, an optical bandpass filter paper for 
filtering the incident laser light, a CCD sensor, a microprocessor for analyzing the image 
formed on the CCD sensor and an inexpensive LCD screen for displaying the final WBC 
count.   
 
Figure 6.3: Schematic of the proposed benchtop WBC counting system. The integrated 
biochip (cell trapping module + microlens array) will constitute the disposable part of the 
system. The benchtop reading equipment will comprise of the optical components like 




Though the proposed integrated system is targeted towards point-of-care WBC 
counting applications, we envision that this system can be used as a generic platform for 































Fabrication Process Flow Of The Microfluidic Devices 
 
A.1 Fabrication process flow of the WBC trapping biochip 
This device was used for the size based capture of WBCs. The fabrication process 
flow for this device involved fabrication and integration of two modules, a) the cell 
trapping module and b) the sample delivery module, as explained below. 
 
a) The cell trapping module - The trapping module consists of an array of 4 μm in 
diameter microholes patterned on a silicon nitride layer. 
Step 1: Wafer prefurnace clean 
The silicon wafers were cleaned using standard prefurnace clean procedure to remove 
organic and ionic contaminants from the wafer surface. Wafers were dipped in a beaker 
containing 1 liter each of hydrogen peroxide (H2O2) and ammonium peroxide (NH4OH) 
to remove organic contaminants like grease, dust particles and solvent residue. This was 
followed by immersing the wafers in a 1:100 hydrofluoric acid (HF) solution to remove 
the oxide layer. Subsequently, the wafers were dipped in a beaker containing 850 ml each 
of hydrogen peroxide (H2O2) and hydrochloric acid (HCl) to remove the ionic 
contaminants. The wafers were subsequently rinsed and dried using deionized (DI) water 




Step 2: Low pressure chemical vapor deposition (LPCVD) of silicon oxide and low 
stress silicon nitride  
The prefurnance cleaned wafers were loaded in a LPCVD furnace for deposition of 1.28 
μm silicon oxide. This was followed by the deposition of a 1 μm thick layer of LPCVD 
low stress silicon nitride.  
Step 3: Photolithographic patterning of the microhole array   
The silicon wafer (with LPCVD silicon oxide and silicon nitride) was vapor primed with 
a photoresist adhesion promoter HMDS (Hexamethyldisilazane) in an oven. 
Subsequently, a 3 μm thick layer of SPR 220 3.0 photoresist was spun on the primed 
wafer at 3000 rpm followed by baking the spun photoresist in a 115 ºC oven for 45 
seconds. The photoresist was exposed to ultraviolet (UV) rays through a photomask for 
0.35 seconds using the GCA ACS 200 AutoStep exposure tool. The wafer was 
subsequently baked in a 115 ºC oven for 90 seconds followed by development of 
photoresist in AZ 300 MIF developer for 60 seconds. All the photolithographic patterning 
steps except the exposure step were performed using the ACS 200 cluster tool. An array 
of 4 μm in diameter microholes was obtained in the photoresist layer subsequent to this 
step. The wafer was hard baked on a 120 ºC hot plate for 10 minutes. 
Step 4: Etching of the low stress silicon nitride 
Using the patterned photoresist layer as the etch mask, the microhole array was etched on 
the silicon nitride layer using the reactive ion etching (RIE) technique. A nitride etching 
recipe (nitride etch rate 34 nm/min, photoresist etch rate 25 nm/min) on the Plasma-
Therm 790 RIE tool was used for this step. Subsequently the photoresist layer was 
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stripped off by immersing the wafer in hot PRS 2000 (a positive photoresist stripper) for 
10 minutes. 
Step 5:  Etching of silicon oxide 
The wafer was immersed in a 1:10 solution of HF in DI water to perform an isotropic 
time etch of silicon oxide layer. An etch time of 8 minutes ensured the formation of 
microfluidic network in the silicon oxide layer. The wafer was rinsed in a bath of DI 
water for 10 minutes subsequent to the HF time etching step. 
Step 6: Dicing of individual dies 
The wafer with patterned microholes and silicon oxide microfluidic network was diced 
manually into individual dies using a silicon scribe. Since the individual dies were 
parallel to the wafer flat, they were easily obtained by cleaving the wafer in <110> 
direction.  
 
b) The sample delivery module - It consisted of a network of microfluidic channels 
patterned in polydimethylsiloxane (PDMS) elastomer using soft lithography. The 
mold for casting the PDMS was made from SU-8 photoresist using standard 
photolithography technique.       
Step 1: Wafer dehydration 
A silicon wafer was dehydrated on a hotplate at 180° C for approximately 10 minutes. 
            Step 2: Spinning SU-8 photoresist 
            SU-8 2015 photoresist was used for mold fabrication as the desired microfluidic channel 
thickness was 20 μm. SU-8 2015 photoresist was spun on the silicon wafer for 5 sec @ 
500 rpm and for 30 sec @ 2000 rpm to obtain a thickness of 20 μm.
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Step 3: Soft baking the photoresist 
            The wafer was soft baked on a hot plate for 1 min @ 65 °C and for 4 min @ 95 °C.  
Step 4: Exposure to UV rays 
            The wafer was exposed to UV through a photomask in ‘soft contact’ mode using a Karl 
Suss MA/BA-6 Mask Aligner tool (lamp power 20 mW/cm
2
). An exposure time of 9 
seconds was used for this step 
Step 5: SU-8 Post-exposure bake 
            The wafer was baked on a hotplate for 1 min @ 65 °C and for 5 min @ 95 °C.  
Step 6: Developing SU-8 photoresist 
The baked SU-8 photoresist was developed using ‘SU-8 Developer’ for approximately 5 
minutes. The wafer was rinsed with iso-propanol and dried using a N2 gun.  
Step 7: Hard baking the SU-8 mold 
The wafer was baked on a hotplate for 10 min @ 180 °C. 
Step 8: Silanization of the SU-8 mold 
The SU-8 mold was placed in a vacuum chamber along with a small quantity of a 
silanizing agent such as Trimethylchlorosilane (TMCS) and silanized for approximately 
30 minutes. 
Step 9: Mixing PDMS prepolymer with curing agent 
A 50 g PDMS prepolymer was mixed with the curing agent in the ratio 10:1. 
      Step 10: Pouring the prepolymer-curing agent mixture onto the SU-8 mold 
The SU-8 mold was placed in a petri dish and fixed using a scotch tape. Subsequently, 




Step 11: Degassing PDMS 
The petri dish containing the mold was placed in a vacuum chamber until all the air 
bubbles were removed.  
Step 12: Curing PDMS 
The petri dish was placed in an oven at 65 °C for 2 hrs. The solidified PDMS was peeled 
off the mold and divided into individual sample delivery module using a sharp blade.    
Step 13: Punching inlet and outlet holes in the sample delivery module 
The inlet and the outlet holes were drilled using a 19 gauge stainless steel needle (0.031 
inch inner diameter, 0.042 inch outer diameter; Kahnetics) (sharpened by electrolysis in a 
phosphoric acid solution).   
Step 14: Cleaning the inlet and outlet holes 
Drilling holes inside PDMS generates a significant amount of scrap that can easily clog 
the microfluidic channels. To clean this scrap, the inside surface of the hole was rubbed 
with a 25 gauge needle (1.5 inch, Becton-Dickinson) and the PDMS particles stuck on the 
inside surface were removed. This step completed the fabrication of the sample delivery 
module.  
 
Bonding the cell trapping module to the PDMS sample delivery module  
The cell trapping module is plasma bonded to the sample delivery module using air 
plasma (March Asher tool) at 30 W and 120 mTorr for 15 s. Alignment marks patterned 
on both the modules were used to align the microhole array (in the trapping module) with 
the microfluidic network (in the delivery module) before bonding. The bonded biochip 
was placed on a 65 °C hot plate for 10 minutes to increase the bond strength. 
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A.2 Fabrication process flow of the polymer-based microlens array 
The planar polymer-based microlens array can be used for simultaneous imaging 
of a large number of micron-sized objetcs. The fabrication process flow for this device 
can be divided into three modules, a) fabricating two master molds from SU-8 photoresist 
using standard photolithography, b) fabricating the inflatable PDMS mold from the 
master molds using soft lithography and c) fabricating the microlens array from the 
inflatable mold, as explained below. 
 
a) Fabrication of SU-8 master molds – Two master molds were fabricated using SU-8 
photoresist using similar photolithography steps as explained in A.1 (b).  
Fabrication of the first SU-8 master mold  
It involved successive patterning of two layers of SU-8 photoresist. Briefly, a silicon 
wafer was dehydrated and SU-8 2007 photoresist was spun at 1000 rpm for 30 sec to 
obtain a thickness of ~13 μm. This was followed by soft baking the wafer at 65 °C for 1 
min and 95 °C for 3 min. The wafer was then exposed to UV through a photomask in 
‘soft contact’ mode using the MA/BA-6 Mask Aligner Tool for 8 seconds. The wafer was 
baked post exposure at 65 °C for 1 min and 95 °C for 4 min and subsequently developed 
in the SU-8 developer for 3 min. The wafer was then hard baked at 180 °C for 10 min. 
This completed the fabrication of the 13 μm thick microfluidic network on the silicon 
wafer.  
Subsequently a second layer of SU-8 was patterned on this microfluidic network. SU-8 
2025 photoresist was spun at 2000 rpm for 30 sec to obtain a thickness of ~40 μm. This 
was followed by soft baking the wafer at 65 °C for 2 min and 95 °C for 6 min. The wafer 
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was then exposed to UV through a photomask in ‘soft contact’ mode using the MA/BA-6 
Mask Aligner Tool for 10 seconds. Alignment marks were used to align the features in 
the first SU-8 layer with those in the 2
nd
 photomask. The wafer was baked post exposure 
at 65 °C for 1 min and 95 °C for 6 min and subsequently developed in the SU-8 
developer for 5 min. The wafer was then hard baked at 180 °C for 10 min. Subsequent to 
the lithography of second SU-8 layer, 40 μm thick circular SU-8 microchamber features 
were obtained on the top of 13 μm thick microfluidic channels.  
Fabrication of the second SU-8 master mold  
This SU-8 mold was fabricated to obtain the support PDMS layer. This mold consisted of 
an array of 200 µm x 200 µm microwells that aligned with the circular microchamber 
patterns fabricated in the previous step. For fabrication of this mold, a silicon wafer was 
dehydrated and SU-8 2050 photoresist was spun at 3000 rpm for 30 sec to obtain a 
thickness of ~50 μm. This was followed by soft baking the wafer at 65 °C for 3 min and 
95 °C for 9 min. The wafer was then exposed to UV through a photomask in ‘soft 
contact’ mode using the MA/BA-6 Mask Aligner Tool for 14 seconds. The wafer was 
baked post exposure at 65 °C for 2 min and 95 °C for 7 min and subsequently developed 
in the SU-8 developer for 7 min. The wafer was then hard baked at 180 °C for 10 min. 
This completed the fabrication of the second SU-8 master mold.  
 
b) Fabrication of the inflatable PDMS mold – This involved soft lithography 
technique of casting PDMS elastomer on the two SU-8 master molds followed by 




Step 1: Spinning and curing PDMS membrane on the first SU-8 master mold 
A 20:1 mixture of the PDMS prepolymer and curing agent was mixed and spun (WS-400 
Lite Series Spin Processor; Laurell Technologies Corporation) on the silanized SU-8 
mold at 1750 rpm to obtain a PDMS thickness of ~52 μm. A lesser proportion of curing 
agent to prepolymer (from the usual 1:10 ratio) ensured a softer PDMS membrane which 
was desired for higher deflections. The spun PDMS was then cured in a 65 °C oven for 
30 min. 
Step 2: Casting PDMS on the second SU-8 master mold  
The process was similar to the one explained in A.1 (b). A mixture of PDMS prepolymer 
and curing agent in the ratio 10:1 was prepared and poured on the silanized SU-8 master 
mold to obtain ~1mm PDMS thickness. The SU-8 mold (with prepolymer-curing agent 
mixture) was placed in a vacuum chamber to remove all the air bubbles. Subsequently, 
the mold was placed in a 65 °C oven for 2 hrs to cure the PDMS. The solidified PDMS 
was peeled off the mold and divided into individual dies using a sharp blade.  
Step 3: Bonding the PDMS membrane to the PDMS support module 
The PDMS membrane (on the 1
st
 SU-8 mold) and the PDMS support modules (obtained 
from the 2
nd
 SU-8 mold) were exposed to air plasma (90W, 250 mTorr) for 35 sec. 
Subsequently, the microchamber structures underneath the PDMS membrane were 
aligned with the PDMS support module under a 5x microscope objective and the two 
parts were bonded by placing the assembly in the 65 °C oven for 10 min. This was 
followed by peeling off of the membrane-support layer assembly from the SU-8 master 
mold. Inlet holes (for injecting the UV-curable polymer) were punched in the PDMS 
assembly using a 19 gauge stainless steel needle. 
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Step 4: Bonding the PDMS assembly to the glass coverslip 
The two layer PDMS assembly (obtained from the previous step) and a 175 μm thick 
glass coverslip (Fisherbrand Microscope Cover Glass, Catalog No. 12-544-C) were 
exposed to air plasma (90 W, 250 mTorr) for 35 sec and bonded to each other to obtain 
the sealed inflatable PDMS mold. A hollow steel pin (0.016 inch inner diameter, 0.025 
inch outer diameter; Kahnetics) was attached to the inlet to facilitate chip-to-tube 
interface. 
 
c) Fabrication of the microlens array from the inflatable mold - This involved filling 
a UV-curable polymer into the inflatable PDMS mold under pressure and curing it to 
obtain fixed focal length microlenses. 
Pressure assisted injection of the UV-curable polymer and curing 
A high index of refraction UV-curable polymer (Norland 60, index of refraction n = 1.56) 
was filled in a 3 ml syringe (Becton Dickinson 3 ml syringe, Catalog No. 309582) and 
injected into the inflatable mold under manually applied pressure. When all the air 
bubbles escaped from the PDMS mold (verified manually under a stereomicroscope), the 
inlet was connected to an air supply through a pressure controller (R-800-60 Sub 
miniature pressure regulator, output range 0-60 psi; AIRTROL Inc.). In order to solidify 
the UV-curable polymer at a particular pressure value, the inflatable mold (with 
pressurized polymer) was exposed to UV for 10 minutes under a UV lamp (365 nm 
wavelength; Entela). This resulted into curing of the polymer under the deflected PDMS 




A.3 Fabrication process flow of the doublet microlens array 
The high numerical aperture doublet microlens array can potentially be used for 
high resolution brightfield and fluorescence imaging of cells and tissues. Fabrication of 
the doublet microlens array can mainly be divided into three key processes, a) fabrication 
of the microhole array, b) assembly of glass microspheres on the array and c) spinning of 
a PDMS layer on the captured microspheres 
 
a) Fabrication of the microhole array – Arrays of 56 μm in diameter through wafer 
microholes were etched in a silicon substrate. 
Step 1: Plasma enhanced chemical vapor deposition (PECVD) of silicon oxide  
A 2 μm thick PECVD silicon oxide was deposited on a silicon wafer using GSI PECVD 
tool.  
Step 2: Photolithographic patterning of the microhole array 
A 10 x 10 array of 56 μm in diameter microholes were patterned on the oxide layer using 
SPR 220 3.0 photoresist following same steps as Step 3 of A.1 (a). 
Step 3: Etching of PECVD oxide 
Using the patterned photoresist layer as the etch mask, the microhole array was etched on 
the silicon oxide layer using the deep reactive ion etching (DRIE) tool. An oxide etching 
recipe (oxide etch rate 0.2 μm /min, photoresist selectivity 1:1) on the STS DRIE tool 
was used for this step.  
Step 4: Through wafer etch of the silicon wafer 
Using the oxide layer and residual photoresist as etch mask, through wafer microholes 
were etched in the silicon wafer using the DRIE technique. A silicon etching recipe 
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(silicon etch rate 5 μm/min, photoresist selectivity 47:1, oxide selectivity 500:1) on the 
STS DRIE tool was used for this step. For the through wafer etch, the silicon wafer had 
to be mounted on a carrier wafer using a crystal bond and subsequent to the etching, the 
two wafers were separated by immersing them in a hot PRS bath which dissolves the 
crystal bond.  
Step 5: Thinning of the silicon wafer 
The silicon wafer was thinned down to 200 μm (from the non oxide side) using a lapping 
tool followed by the polishing of the etched surface using the chemical mechanical 
polishing (CMP) tool. This completed the fabrication process for the microhole array. 
Step 6: Dicing of individual dies 
The thinned silicon wafer with patterned microholes was diced manually into individual 
dies using a silicon scribe. 
 
b) Assembly of glass microspheres on the array – Glass microspheres (60 µm 
nominal diameter, refractive index 1.51 at a wavelength of 589 nm; catalog no. 
02718-AB, Structure Probe, Inc.) were assembled on the microhole array.  
Step 1: Fabrication of a PDMS suction port 
A 5 mm diameter hole was punched in a 1 cm thick PDMS piece, which was aligned and 
attached to the microhole array. The PDMS piece adhered to the silicon surface without 
any additional adhesion treatment. A tube connected to a 3 ml syringe was connected to 





Step 2: Dispensing and assembly of glass microspheres 
An aqueous solution of glass microspheres was then dispensed on the oxide-coated 
silicon surface. A suction force was subsequently applied manually from the other side of 
the substrate to assemble and trap the glass microspheres atop of the microhole array. A 
piece of double sided tape was attached on a glass coverslip and the tape was brought in 
contact with the wafer surface resulting into the removal of the extra microspheres. This 
resulted into the assembly of microspheres on the microhole array. 
 
c) Spinning of PDMS on the assembled microspheres – This process completed the 
doublet microlens fabrication by spinning a PDMS layer on the microspheres. 
A 10:1 PDMS prepolymer to curing agent mixture was prepared and spun (WS-400 Lite 
Series Spin Processor; Laurell Technologies Corporation) on the silicon microhole array 
(with assembled microspheres) at 1600 rpm for 1 min. In order to prevent the flying off 
of the microspheres during the spinning step, the lowest acceleration of 108 rpm per sec 
was used. This resulted into a PDMS thickness of ~75 µm. The PDMS was subsequently 
cured on a 65ºC hot plate for one hour. This completed the fabrication process of the 








Opto-mechanical Simulations Of Planar Microlens’ Focal Length And Numerical 
Aperture 
 
In this section, we will describe the opto-mechanical simulations performed to 
characterize the pressure dependence of the effective focal length (EFL) and numerical 
aperture (NA) of the planar, polymer-based microlenses. Pressure dependent deflection of 
the PDMS membrane was obtained using a finite element analysis software ANSYS. The 
resulting microlens profile was imported into an optical design software (OSLO LT) to 
obtain the microlens EFL and NA.  
  
B.1 Microlens profile using ANSYS  
An ANSYS programming code was written to solve for the pressure dependent 
deflection of the PDMS membrane for given dimensions (thickness, diameter). This code 
creates the geometry of the membrane and imparts it the elastic properties (Young’s 
Modulus, Poisson’s Ratio). It meshes the entire structure for the simulation and applies 
constraints on different surfaces. Finally, load (pressure in Pa) is applied on the 
membrane and the resulting membrane deflection is computed. An example ANSYS code 
for solving the deflection of a 60 µm in diameter membrane under 3 psi (200 kPa) 










!creating the geometry of the membrane 
CYLIND, 3e-5, 7e-5, 0, 5.2e-5 




!meshing the struture 
!et for defining the element type 
et, 1, solid95 
 
!defining material properties (Young’s Modulus, Poisson’s Ratio) 
mp, ex, 1, 30e5 











da, 1, all, 0 
da, 3, all, 0 
da, 4, all, 0 
 
!defining loads 
sfa, 7, , pres, 200000 
 





Upon successful run of the program, the resulting membrane deflection can be 




Figure B.1: A representative PDMS membrane deflection (microlens) profile obtained 
using ANSYS mechanical simulations. 
________________________________________________________________________ 
 
There was a difference between the maximum deflection values of the outer and 
the inner surface of the membrane. The inner surface underwent a larger deflection 
resulting into a smaller radius of curvature. The radius of curvature of the inner surface 
was estimated by drawing a circle which passed through the center point (point of 
maximum deflection) and the two edges of the inner surface. Similar process was adopted 
to estimate the radius of curvature of the outer membrane surface. These radii of 
curvature values were used by the optical simulation software (OSLO LT) to compute the 










Figure B.2: Simulation of microlens’ focal length and numerical aperture using OLSO 
software. (A) Lens surface data spreadsheet used for entering the lens material and 
geometrical properties into the software. (B) A ray diagram obtained from the OSLO 
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